Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 192.00
Ask: 238.00
Change: 0.00 (0.00%)
Spread: 46.00 (23.958%)
Open: 215.00
High: 216.00
Low: 215.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Results 2011

18 May 2012 07:00

RNS Number : 6220D
JZ Capital Partners Ltd
18 May 2012
 



 

 

 

 

 

 

FULL YEAR RESULTS FOR THE 12 MONTHS ENDING 29 FEBRUARY 2012

 

~Strong NAV total return driven by five significant realisations and record dividend ~

18 May 2012

 

JZ Capital Partners Limited (LSE:JZCP.L or "JZCP"), the London listed private equity fund that invests in high quality US and European micro cap companies, today announces its audited results for the twelve months ending 29 February 2012.

 

Results Highlights

 

·; 14th consecutive quarter of Net Asset Value (NAV) growth, now exceeding $600 million

·; 7.9% NAV Total Return including:

o NAV of US$615 million, an increase of 5.85% (2010: $581m)

o A record distribution of 25.0c per share (2010: 24.5c per share)

o NAV per share increased to US$9.47 (2010: US$8.93)

·; US$226.1 million of proceeds received, including US$156 million from the sale of five businesses, generating an average multiple of equity capital invested of 5.0x and an average IRR of 27%

·; US$187.3 million invested including 9 investments in companies in the US and Europe with an average entry EBITDA multiple of 5.8x and average leverage of 1.3x

·; New investments made in the secondary mortgage loan market using the investment adviser's experience and track record of credit investing

Significant post period end investment activity

o A US$36.2 million investment in two US industrial micro cap companies and €13.5 million in a precious metals trading business in Spain

o First co-investment in Latin America - US$6.2 million investment in BSM Engenharia, a Brazil based infrastructure service business in conjunction with ACON, a private equity group with significant Latin American experience

o A US$14.25 million investment in 100,000 square feet of retail units and forty apartments in New York City

o Additional secondary of TAL stock realizing $17.0 million

Strategic Initiatives

 

·; Commitment to help provide a long-term solution to the discount to NAV through a new dividend policy which will provide regular and more predictable distributions at a rate of 3% of NAV per year, implying a yield at the discount (as at 16 May 2012) of 4%

·; Proposed admission to trading on the London Stock Exchange's Specialist Fund Market ("SFM") and consequent cancellation of listing on the premium segment of the Official List and trading on the London Stock Exchange's main market for listed securities

- The proposal will enable the Company to have a simplified capital structure through a single class of ordinary shares which will be more appropriate to the mix of investors who own the Company's shares

- It will also remove a structural inadequacy that has restricted the Company's ability to accommodate US investors and will better reflect the Company's reported market capitalization

·; Proposal to increase the Company's current investment limitations on investments in businesses outside the United States from 20 per cent to 30 per cent of the Company's gross assets

·; An investment of up to US$15.0 million in a new asset management business to meet the growing demand from endowments and pension funds in the US for fiduciary management service

Outlook

·; Positive - the Company has an extremely strong balance sheet and remains well positioned to take advantage of a healthy pipeline of investment and realisation opportunities within the micro cap sector

David Zalaznick, JZCP's Founder and Investment Adviser, said:

"I am pleased to announce another excellent set of full year results which includes a record distribution of 25.0c per share and another period of strong NAV appreciation.

"JZCP's micro cap portfolio continues to provide superior returns from recent realizations. Our geographical diversification includes further investments in Spain and Latin America. We have also begun to take advantage of exciting new opportunities in the credit and real estate sectors which will complement our core micro cap strategy.

"A proposed simplification of our capital structure through the transfer to the Specialist Fund Market will enable the Company to continue to grow without potential regulatory and shareholder restrictions and the change in dividend policy will benefit our shareholders with a more predictable and easy to understand dividend."

 

David Macfarlane, Chairman of JZCP, said:

"The results underline the Company's disciplined investment strategy and its focus on providing superior returns for shareholders. In addition, we are proposing several strategic initiatives to further enhance long-term shareholder value and pave the way for the future success of the Company. We look forward to the coming year with confidence."

There will be an analyst and investor presentation to discuss JZCP's recent financial performance and portfolio developments at 9.30am at FTI Consulting, 26 Southampton Buildings, London WC2A 1PB. It can be accessed by dialling +44(0)20 7784 1036 (UK) or +1 646 254 3364 (US) with the participant access code 7495640.

A playback facility will be available two hours after the conference call concludes. This facility may be accessed until 25 May 2012 by dialling +44 (0)20 7111 1244 or UK +1 347 366 9565 US. The code to access the playback facility is 7495640. A recording of the investor call will also be available on JZCP's website within a few days of the call.

 

 

For further information:

 

Neil Doyle/ Ed Berry +44 (0)20 7269 7237 / 7297

FTI Consulting

 

David Zalaznick +1 212 572 0800

Jordan/Zalaznick Advisers, Inc.

 

About JZCP

JZCP is a London listed private equity fund which invests in high quality US and European micro cap companies. Our objective is to achieve a superior overall return comprised of a current yield and significant capital appreciation. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. ("JZAI"), founded by David Zalaznick and Jay Jordan, which has advised JZCP for twenty five years and has investment professionals and offices in New York, Chicago, London and Madrid. JZAI's experts work with the existing management of micro cap companies to help build better businesses, create value and deliver strong returns to our investors. JZCP also invests in mezzanine loans, first and second lien investments and other publicly traded securities. For more information please visit www.jzcp.com

 

 

Chairman's Statement

 

I am pleased to report the results of JZ Capital Partners Limited ("JZCP" or the "Company") for the twelve-month period ended 29 February 2012 and a number of strategic initiatives which are aimed at ensuring the future success of the Company and generating more stable, superior long-term returns for our shareholders.

 

PerformanceThe Company's disciplined, value-orientated investment approach has once again provided a solid platform for another strong set of full year results and has provided the 14th consecutive quarter of Net Asset Value ("NAV") growth; including dividends paid, we have shown a total NAV return for the last three years of 18%. This is an excellent achievement considering the sustained challenging trading environment, which remained unpredictable throughout the period, despite glimpses of an equity market rally towards the end of 2011.

 

The positive performance of the underlying assets led to a 6% increase in NAV to US$615 million (2010: US$581 million) giving rise to a NAV per share of US$9.47 per share (2010: US$8.93). The Board is pleased to announce a record full year distribution of US$16.3 million (2010: US$15.9 million) or 25.0 cents per share (2010: 24.5 cents per share), providing shareholders with a total NAV return (NAV appreciation and reinvested dividends) of 8%.

 

The Company has built on the heightened levels of investment activity during 2010 with further investments and realisations across the core portfolio during the period. Investing in good quality companies with strong growth prospects remains a continued focus for JZCP and the Company continues to exploit a broad range of industry verticals and geographies to originate suitable assets. At the end of the period the portfolio consisted of 44 companies across 10 industry sectors and within the US, Europe and now Latin America.

 

Valuations in the micro cap space, the main growth driver for JZCP, held up well relative to the rest of the private equity sector and the Company was able to make five significant realisations generating US$156 million. The US micro cap portfolio continues to form the mainstay of the Company's investment and realisation activity and 2011 was no exception, with US$53.3 million of investments made during the period, with an average entry multiple of 5.8x.

 

Our exposure to the European micro cap sector continues to compliment and diversify the US micro cap portfolio and is becoming a strategically important segment of the business. The challenging economic environment in Spain has provided five investment opportunities for the Company to date and we continue to explore other opportunities at distressed prices in the region and across Europe. Our European portfolio represents 12% of NAV as at 29 February 2012 (now 14% of NAV since period end).

 

Since the period end, we have started to exploit our value-orientated approach in Latin America, a market with a positive demographic trend that has huge growth potential and importantly it will provide our portfolio with further geographic diversification. Due to the strong performance of our European portfolio and the considerable scope for further activity in the region and further co-investment opportunities in Latin America, the Board feels that it is in the interest of all shareholders to have the option to increase the percentage of the portfolio which can be invested outside the US from 20% to 30% of the portfolio.

 

I'm also pleased to report some other exciting opportunities that will complement our core micro cap strategy. Our track record of investing in credit and the current dislocation in the real estate market has led us to some quality investment opportunities in the secondary mortgage loan market. These assets have the potential to provide a high yield and capital appreciation, so fit nicely within the Company's risk reward profile.

 

JZCP is also taking advantage of opportunities within the New York retail and commercial real estate market through a new partnership with a real estate developer.

 

Separately the Company is establishing a new asset management business in the US that will address the growing demand from endowments and pension funds for fiduciary management services. We look forward to updating the market on the progress of these early stage investments later in the year.

 

Strategic Initiatives

The Company continues to experience interest from a number of investors from the US, which are attracted by the shareholder returns generated by JZCP. With that in mind, shareholders will be receiving a communication about a proposed restructuring of the Company's Ordinary share capital, the rationale for which I would like to address briefly below.

 

The Company has had an equity capital structure to date which has included listed Ordinary shares and unlisted Limited Voting Ordinary shares (LVOs). This structure restricts the Company's ability to accommodate the growing number of US investors looking to invest in JZCP, as outlined above

 

In light of this trend and given the potentially onerous and costly US regulatory consequences caused if voting control of JZCP is owned by US shareholders, the Board feels that it is in the interest of all shareholders to devise a capital structure that resolves this issue on a permanent basis. The Board has explored a wide range of options and has concluded that this shareholder restriction be removed by a restructuring of JZCP's capital that includes a change to a single class of Ordinary shares.

 

Part of the proposed structure is that there are restrictions on the voting rights of shareholders who cannot or do not confirm that they are not US persons. This would mean JZCP's Ordinary shares would not be eligible for listing on the premium segment of the Official list and would be transferred, together with the ZDP shares, for admission to trading on the London Stock Exchange's Specialist Fund Market (SFM).

 

The new capital structure will provide the following benefits to shareholders:

 

- Better reflect the Company's market capitalization

- Promote a free flow of Ordinary shares giving improved access for US investors

- Provide a resolution of existing US securities laws regulatory risk

- All ordinary shareholders will hold a single class of listed Ordinary shares

- No forced conversion or sell downs as required under the current situation when the percentage of US shareholders exceeds 50%

 

These proposals are subject to shareholder approval and further information can be found in the Circular distributed to shareholders and in today's separate regulatory announcement.

 

DistributionsThe Directors declared and paid an Interim Dividend of 3.5 cents per share for the six months ended 31 August 2011 and paid a Special Dividend in respect of that period of 3 cents per share. The Board recommends a final dividend for the year of 18.5 cents per share. Therefore, subject to shareholder approval of the proposed Final Dividend, the total distribution for the year will be 25.0 cents per share, compared to 24.5 cents for the year ended 28 February 2011. Much of this additional 18.5 cents is due to significant cash income generated from Paid in Kind ("PIK") interest and preferred dividends paid in cash from the realizations mentioned above.

The Board continues to be mindful of the significant discount to NAV at which the Company, and the majority of the wider listed private equity sector market is trading and continually explores options that are aimed at providing a long-term solution to narrow the discount.

 

Accordingly the Board is proposing to make dividend distributions that are regular and predictable, through a change in dividend policy.

Historically it has been the policy to distribute, as regular interim and final dividends, the majority of JZCP's net cash income and as special dividends non-cash income, largely PIK interest, when it is converted into cash. Whilst recently the Board has been able to say that conditions are tending to be such as to allow the payment of special dividends, their payment has been irregular in terms of amount and timing and at the same time as a result of low interest rates, net cash income is tending to reduce. Accordingly shareholders have had no certainty of yield or progression.

 

The distribution for the year ended 29 February 2012 has been determined on the historic basis. But for the current financial year and thereafter it will be the Directors' policy that the dividend will be calculated as 3 per cent of NAV per year (1.5 per cent at each of the interim and final stages) implying a yield at the discount (as at 16 May 2012) of approximately 4 per cent.

 

OutlookThe outlook for the Company continues to be positive: we are well positioned to take advantage of a healthy pipeline of investment and realisation opportunities in the micro cap sector in US and Europe whilst pursuing some exciting investments diversified by industry and geography.

 

As outlined above, our shareholders will have the opportunity shortly to vote on a number of strategic initiatives that have been proposed to further enhance long-term shareholder value and that the Board believes will pave the way for the future success of the Company. We look forward to the year ahead with confidence.

 

 

David Macfarlane

Chairman

 

17 May 2012

 

 

Report of the Directors

 

The Directors present their annual report together with the audited financial statements of JZ Capital Partners Limited (the "Company") for the year ended 29 February 2012.

 

Principal Activities

JZ Capital Partners is a closed-ended investment company with limited liability which was incorporated in Guernsey on 14 April 2008 under The Companies (Guernsey) Law, 1994. The Company is subject to the Companies (Guernsey) Law, 2008. The Company's Share Capital consists of Ordinary shares and Zero Dividend Preference ("ZDP") shares. The Ordinary and ZDP shares were admitted to the official list of the London Stock Exchange on 27 June 2008.

 

The Company was granted consent on 8 May 2008 by the Guernsey Financial Services Commission under The Control of Borrowing (Bailiwick of Guernsey) Ordinance,1959 to raise up to £300,000,000 by the issue of shares.

 

The Company was launched in connection with a scheme of reconstruction and voluntary winding up of JZ Equity Partners Plc ("JZEP") under section 110 of the United Kingdom's Insolvency Act 1986. JZEP's assets, after providing for its liabilities were transferred in specie to the Company and the Company issued to JZEP shareholders (other than those who opted against the new scheme) one Ordinary share for each JZEP Ordinary share and ZDP share for each JZEP ZDP share that they held.

 

On 22 June 2009 a placing and open offer of Ordinary shares resulted in 117,037,749 Ordinary and 110,527,388 Limited Voting Ordinary shares being issued at the price of 42 pence. The Ordinary shares were subsequently consolidated on the basis that all holders of Ordinary shares would hold one Ordinary share for every five Ordinary shares held immediately prior to the share consolidation. New ZDP shares were also issued following the redemption of the old ZDP shares.

 

Limited Voting Ordinary ("LVO") shares were issued so that certain of the Company's existing shareholders and certain new investors that are Qualifying US Persons* could participate in the Ordinary share Issue without causing the Company to be treated as a US domestic company for the purposes of US securities laws and/or a Controlled Foreign Company ("CFC") for US tax purposes. LVO shares are identical to, and rank pari passu in all respects with, the new Ordinary shares except that the LVO shares will only carry a limited entitlement to vote in respect of the appointment or removal of Directors and do not carry any entitlement to vote in respect of certain other matters. The LVO shares are not listed and are not admitted to trade on or through the facilities of the London Stock Exchange.

 

Business Review

The total profit attributable to Ordinary shareholders for the year was US$45,044,000 (year ended 28 February 2011: profit of US$137,243,000). The revenue return for the year was US$25,202,000 (year ended 28 February 2011: US$30,120,000), after charging administrative expenses of US$2,786,000 (year ended 28 February 2011: US$2,094,000) and Investment Adviser's base fee US$10,247,000 (year ended 28 February 2011: US$8,667,000) and an income incentive fee payable to the investment adviser of US$4,410,000 (28 February 2011: US$nil). The net asset value (NAV) of the Company at the year end was US$615,462,000 (28 February 2011: US$580,788,000) equal to US$9.47 (28 February 2011:US$8.93) per Ordinary.

 

For the year ended 29 February 2012, the Company had US$1,633,000 (year ended 28 February 2011: US$15,056,000) of cash inflows resulting from operating activities.

 

A review of the Company's activities and performance is detailed in the Chairman's Statement and the Investment Adviser's Report.

 

The Directors' valuation of the listed and unlisted investments is detailed in the Investment Review.

 

Dividends

An interim dividend of 3.5 cents per Ordinary share (total US$2,275,651) and a special dividend of 3.0 cents (total US$1,501,558) was declared by the Board on 17 October 2011 and paid on 25 November 2011.

 

A final dividend of 18.5 cents per Ordinary share (total US$12,028,443) was proposed by the Board on 17 May 2012.

 

For the year ending 28 February 2013, it will be the Board's intention to distribute substantially 3% of the Company's net assets in the form of dividends.

 

 

Directors

The Directors listed below are all non-executive and have served on the Board throughout the year and were in office at the end of the year and subsequent to the date of report.

 

David Macfarlane (Chairman)

David Allison

Patrick Firth

James Jordan

Tanja Tibaldi

 

All Directors are independent at the year end and throughout the year and to the date of this report.

 

*A foreign corporation shall satisfy the "qualified US person ownership test" if, for more than half the days of the corporation's taxable year:

 

(i) it is a CFC, and (ii) more than 50% of the total value of all the outstanding stock of the CFC is owned by one or more "qualified US persons".

 

Annual General Meeting

The Company's Annual General Meeting is due to be held on 3 July 2012.

 

Share Capital and Purchase of Own Shares

Details of the Zero Dividend Preference shares and the Ordinary shares can be found in Notes 17 and 18] respectively. During the year the Company did not buy back any of its own shares.

 

The beneficial interests of the Directors in the Ordinary shares of the Company are shown below.

 

David Allison and Patrick Firth did not hold an interest in Ordinary shares during the year. None of the Directors held any interest in the Zero Dividend Preference shares during the year. There have been no changes in the Directors' interests between 29 February 2012 and the date of this report.

 

Number of

Ordinary shares

1 March 2011

Ordinary shares purchased/

(sold)

Number of ordinary shares

29 February 2012

David Macfarlane

40,000

3,000

43,000

James Jordan

30,000

-

30,000

Tanja Tibaldi

2,000

-

2,000

72,000

3,000

75,000

 

Directors' Statement as to the Disclosure of Information to the Auditors

All the present Directors were members of the Board at the time of approving this report, and each of the Directors confirms that:

 

• To the best of his/her knowledge and belief, there is no information relevant to the preparation of this report of which the Company's auditors are unaware; and

 

• He/she has taken all the steps a Director might reasonably be expected to have taken to be aware of relevant audit information and to establish that the Company's auditors are aware of that information.

 

Independent Auditor

A resolution to re-appoint Ernst & Young LLP as auditor to the Company will be proposed at the next annual general meeting.

 

Substantial Shareholders

As at 29 February 2012 the Company has been notified in accordance with applicable legislation of the following interests in the Ordinary share capital and Limited Voting Ordinary ("LVO") share capital of the Company:

 

Ordinary

shares

 

LVO

shares

 

 

Total

% of Ordinary shares

% of

total

shares

Rothschild Private Management Ltd*

3,894,018

-

3,894,018

10.43%

5.99%

Abrams Capital Management, LP

3,362,450

1,030,053

4,392,503

9.01%

6.76%

John W. Jordan

2,513,280

5,251,037

7,764,317

6.73%

11.94%

David W. Zalaznick

2,466,340

5,251,037

7,717,377

6.61%

11.87%

Edgewater Growth Capital Partners

2,111,613

11,382,424

13,494,037

5.66%

20.75%

Leucadia Financial Corporation

1,941,550

2,586,013

4,527,563

5.20%

6.96%

M&G Investment Management Ltd**

1,912,504

-

1,912,504

5.12%

2.94%

Baillie Gifford***

1,822,630

-

1,822,630

4.88%

2.80%

Legal & General****

1,397,076

-

1,397,076

3.74%

2.15%

 

*At the date of this report (17 May 2012) Rothschild Private Management Limited held 3,921,118 Ordinary shares and no Limited Voting Ordinary shares in the Company.

**At the date of this report (17 May 2012) M&G Investment Management Ltd held 1,912,449 Ordinary shares and no Limited Voting Ordinary shares in the Company.

***At the date of this report (17 May 2012) Baillie Gifford held 1,820,523 Ordinary shares and no Limited Voting Ordinary shares in the Company.

****At the date of this report (17 May 2012) Legal & General held 1,361,458 Ordinary shares and no Limited Voting Ordinary shares in the Company.

All other holdings were the same as at the year end and 17 May 2012.

 

The percentage of Ordinary shares shown above represents the ownership of voting rights at the year end (LVO shares are not classed as having voting rights).

 

It is the responsibility of the shareholder to notify the Company of any change to their shareholdings when it reaches 3% of shares in issue and any change which moves up or down through any whole percentage figure above 3%.

 

Statement of Directors' Responsibilities

The Directors are responsible for preparing the Financial Statements in accordance with International Financial Reporting Standards as adopted by the European Union ("IFRS") and the Companies (Guernsey) Law, 2008 for each financial period which give a true and fair view of the state of affairs of the Company and its profit or loss for that period. International Accounting Standard 1 requires that financial statements present fairly for each financial period the Company's financial position, financial performance and cash flows. This requires the faithful representation of the effects of transactions, other events and conditions in accordance with the definitions and recognition criteria for assets, liabilities, income and expenses set out in the International Accounting Standards Board's "Framework for the preparation and presentation of financial statements". In virtually all circumstances a fair presentation will be achieved by compliance with all applicable International Financial Reporting Standards.

 

In preparing Financial Statements the Directors are required to:

 

• Ensure that the Financial Statements comply with the Memorandum & Articles of Incorporation and IFRS, as published by the International Accounting Standards Board;

 

• Select suitable accounting policies and apply them consistently;

 

• Present information including accounting policies, in a manner that provides relevant, reliable, comparable and understandable information;

 

• Make judgements and estimates that are reasonable and prudent;

 

• Prepare the Financial Statements on the going concern basis, unless it is inappropriate to presume that the Company will continue in business; and

 

• Provide additional disclosures when compliance with the specific requirements in IFRS is insufficient to enable users to understand the impact of particular transactions, other events and conditions on the Company's financial position and financial performance.

 

The Directors confirm that they have complied with these requirements in preparing the Financial Statements.

 

Responsibility Statement of the Directors in Respect of the Financial Statements

Each of the Directors confirms to the best of each person's knowledge and belief that:

 

• The Financial Statements, prepared in accordance with IFRS and in accordance with the requirements of the London Stock Exchange ("LSE"), give a true and fair view of the assets, liabilities, financial position and profit of the Company; and

 

• The Investment Advisers' Report includes a fair review of the development and performance of the business and the position of the Company together with a description of the principal risks and uncertainties faced by the Company.

 

The Directors are also responsible for the keeping of proper accounting records which disclose with reasonable accuracy at any time, the financial position of the Company and to enable them to ensure that the Financial Statements comply with the Companies (Guernsey) Law, 2008 and the Listing Rules of the London Stock Exchange. They are also responsible for the system of internal controls, safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

The Directors are also responsible for the maintenance and integrity of the corporate and financial information included on the Company's website. Legislation in the United Kingdom and Guernsey governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

 

Approved by the Board of Directors and agreed on behalf of the Board on 17 May 2012.

 

 

David Macfarlane Patrick Firth

Chairman Director

 

Investment Adviser's Report

 

 

We are pleased to report JZCP completed its fiscal year ending 29 February 2012 with strong investment returns, year on year growth in Net Asset Value ("NAV") and a substantial dividend distribution to shareholders. Our NAV (including dividends paid) was up 7.9%; on a per share basis the NAV went up to US$9.47 per share from US$8.93. JZCP's dividend will be 25.0 cents versus 24.5 cents last year. Our Company's balance sheet is exceptionally strong with enhanced liquidity from multiple realizations and repayment of debt investments. We received US$247.8 million in proceeds from realizations and deployed US$291.3 million in new investments over the past fourteen months.

 

Our NAV growth for the year was driven by (i) five successful realizations (ii) and positive performance in our underlying investments. Our robust dividend was provided in part, by realizations of the portfolio which resulted in cash payment of accrued income. Starting with this financial year ending 28 February 2013, it is the Board's intent to prescribe an annual dividend equal to 3% of JZCP's NAV; assuming this occurs, dividends, comprised of capital and income returns, will be paid to shareholders at a predictable rate that will not be subject to the dependence on realizing accrued income for a portion of the dividend.

 

Our investment style is relatively simple: we are value oriented investors that primarily buy already successful businesses in partnership with management at reasonable prices. We have worked with the respective management teams on strategic acquisitions, and over the years we have added operational improvements to help grow the value of our portfolio companies. We believe this is the way to achieve superior returns with less risk.

 

We have diversified JZCP's portfolio into many different industry sectors as well as geographically across the United States, and more recently, into Europe. As you will see in this report, we have started to add asset classes, such as real estate and distressed debt, applying the same disciplined investment approach we have always used.

 

Currently (May 2012), we have businesses in 10 different sectors. In addition, we have invested US$0.8 million in distressed debt, US$16.8 million in real estate and US$61.4 million in listed corporate bonds.

 

NAV Growth

 

For the twelve months ending 29 February 2012, JZCP's net assets increased from US$8.93 per share to US$9.47, a 6% increase (after the 16 cents of dividends paid in the same period), posting 14 consecutive quarters of growth. The chart below shows the source of JZCP's annual growth for this fiscal year:

 

Net Asset Value per Ordinary share as of 28 February 2011

US$8.93

+ Increase in underlying investments

0.52

- Decrease in listed equities

(0.09)

+ Income from investments

0.67

- ZDP dividend accrual

(0.10)

- Dividends paid

(0.16)

- Fees and expenses

(0.20)

+/- Other

(0.10)

Net Asset Value per Ordinary share as of 29 February 2012

 

US$9.47

Regarding the Increase in Underlying Investments above, over the course of the year, we have increased the valuation of four US micro cap businesses through both realized (20 cents) and unrealized (12 cents) means. We reduced the valuations of four US micro cap investments due to soft earnings performance (28 cents). In addition, we booked an increase in the valuation of the EuroMicrocap Fund investments, through the over-performance of Factor Energia, a Spanish power reseller (31 cents per share). Finally, the sale of Advanced Chemistry & Technology, Inc., a legacy investment contributed 8 cents to the NAV growth.

 

Portfolio Summary

 

Below is a comparison of our portfolio, comparing the year ended 29 February 2012 to previous year end. As you will note, our US micro cap portfolio decreased by US$50 million because we had two outstanding realizations (discussed below). Since 29 February 2012, we have completed three US micro cap investments (US$38.1 million), and two businesses outside the US (US$19.4 million).

 

29/02/2012

28/02/2011

Change

US$'000

US$'000

%

US micro cap portfolio

181,655

230,601

(21.2%)

European micro cap portfolio

85,129

32,899

158.8%

Mezzanine investments

29,632

48,499

(38.9%)

Legacy portfolio

25,312

42,620

(40.6%)

Total private investments

321,728

354,619

(9.3%)

Listed equity

88,639

105,016

(15.6%)

Listed corporate bonds

32,129

-

-

Bank debt

32,512

34,121

(4.7%)

Treasury gilts

33,465

-

-

Cash and cash deposits

202,481

172,267

17.5%

Total listed investments (and cash)

389,226

311,404

25.0%

Total investments (and cash)

710,954

666,023

6.7%

Other current assets

451

464

-

Total assets

711,405

666,487

6.7%

 

Note that we have begun a program to purchase highly rated listed corporate bonds, as a means of earning an enhanced return on our cash. The obligors of these bonds are three highly rated banks: HSBC, JP Morgan Chase and Wells Fargo and mature from 2014 to 2016.

 

Micro Cap Portfolio

 

We had significant activity in our US and European micro cap portfolio, investing US$180.4 million over the past year (including the two months past the end of the fiscal year). The average entry multiple was 5.6x and the average leverage was 1.2x.

 

US investments

 

• As part of our strategic build up in sensors, in December 2011 we invested US$22.5 million to acquire a 33% stake in Amptek, Inc., a designer and manufacturer of x-ray detectors. The investment consists of 7% preferred and common stock. We are very pleased to partner with Amptek's very accomplished and motivated management team. This is our second investment in our Sensors vertical, managed by Gerry Posner.

• In August 2011, we made our third Industrial Services vertical acquisition - Southern Parts and Engineering Company ("SPECO"), an independent supplier of aftermarket products and services for industrial air compressors. The company provides internal parts, filters, and lubricants for most reciprocating and rotary OEM brands of compressors. Our US$6.6 million investment in SPECO consists of US$4.5 million of 10% notes and US$2.1 million of preferred and common stock, representing 34% of the equity in this business.

• We acquired Nashville Chemical, in March 2011 which was the first investment into our water vertical. Nashville Chemical is a speciality water treatment, chemical and services company; which treats boilers, cooling water, and process water systems for industrial and commercial customers. Nashville Chemical's water treatment solutions remove harmful contaminants from water, which ultimately improve the efficiency and extend the life of its customer's assets.

• Our US$7.0 million investment in this entity consists of US$3.8 million in notes, and US$3.2 million of preferred and common stock representing a 33% ownership in this company.

• In June 2011, we co-invested with Baird Capital Partners in Justrite, a leading designer and manufacturer of safety products for the handling and storage of flammable and hazardous liquids. Manufacturers, laboratories, commercial buildings and other users of flammable and hazardous liquids rely on Justrite products to comply with regulatory requirements, meet safety codes and prevent catastrophic events caused by fires or spillage. We invested US$4.4 million in preferred and common stock, representing a 11% ownership in this company.

• Throughout the year we invested an additional US$10.0 million in Milestone Aviation, a helicopter leasing business, bringing our investment stake in this business' preferred and common stock to US$12.9 million. This investment represents 8% of Milestone equity.

In April 2012, we purchased Bay Valve Service and Engineering, a Seattle Washington based refurbisher of larger valves for a variety of end users, from oil refineries to power generation plants. Bay Valve is part of our Industrial Service solutions vertical overseen by Jim Rogers. We invested US$18.7 million in debt and equity securities, including 31% of the business's equity. We are excited to add Bay Valve to the ISS family of businesses, including Horsburgh and Scott gears, MidAmerican rubber plant services, and SPECO compressors.

In April 2012, we made an investment in Medplast/UPG, a plastic molding company specializing in high margin healthcare molded products. This business has 10 plants around the world, using a variety of proprietary techniques. Baird Capital Partners, is the lead investor in this transaction; we purchased US$17.5 million of securities, including US$10.0 of 14.5% subordinated notes and US$7.5 million of preferred and common equity. The equity represents a fully diluted 11% of the business.

• We also made a commitment of up to US$15.0 million into a new asset management portfolio company, run by David Russ. David brings with him an impressive track record as Chief Investment Officer of Dartmouth College's endowment, as well as having senior investment roles at Stanford University and the Regents of the University of California. His plan is to approach smaller endowments and pension funds who have limited resources and offer them an institutional grade investment management program; this type of asset management business is known as an "outsourced CIO/Endowment model." We are excited to be working with David and will report more on this business as developed.

 

European investments

 

JZCP is investing in the European micro cap sector through its 75% ownership of the EuroMicrocap Fund ("EMF"). Exposure to the European micro cap sector continues to compliment and diversify JZCP's existing micro cap portfolio and 2011 saw significant activity in this strategically important sector. As at 29 February 2012, the European micro cap portfolio represented 11% of total NAV, and now 14% of NAV after our investment in Oro Direct (described below) this past March.

 

As you may recall, we have an office in London and Madrid and an outstanding team with over ten years of investment experience in European micro cap deals. During the fiscal year ended 29 February 2012 (plus the two months following) EMF has made the following investments.

 

• In April 2011, EMF acquired Docout, a provider of digitalization, document processing and storage services to Spanish financial institutions, utilities and insurance companies. EMF invested €11 million in equity and JZCP directly loaned Docout €2.0 million for working capital. Docout was awarded the largest document outsourcing contract from Bank Santander just prior to its acquisition. Docout has already begun to expand its business to Latin America and the UK in conjunction with its large customers.

• In May 2011, EMF made a €12.7 million investment in Grupo Ombuds, a leading provider of security, surveillance and facility services to public sector and blue-chip clients in Spain. JZCP also loaned the company €5.0 million in a 8.0% senior debt and €3.5 million in 15% junior debt (5% cash and 8% PIK).Ombuds' service offering includes personal security protection to government officials and corporate executives, asset protection, security services to public and corporate buildings and the provision of ancillary facility services. The company is a niche player with strong growth potential and has a leading market share in Spain.

• In March 2012, EMF acquired 29.7% of Oro Direct, a leading precious metals trading business in Spain. EMF invested €13.5 million along side a co-investor, LFPI, which invested €11.5 million for 25.3% interest. Based in Valencia, Spain, Oro produces scrap gold and silver from 1,500 pawn shops and jewelers for the spot price less a commission per kilo transacted. The precious metals are then sold on to a refiner in Switzerland. This business is very scalable and opened an office in Vienna immediately after our transaction.

The EMF made two additional investments during fiscal 2011, JZCP's share through EMF of all five of its investments represented 14% of JZCP's total assets as at 29 February 2012.

 

Significant realisations

 

In July 2011, we sold one of our oldest investments, Advanced Chemistry & Technology, Inc. for a significant gain. JZCP received US$18.2 million for its US$3.4 million investment, representing a 5.6x multiple of capital invested. This sale represented a US$5.5 million increase in NAV, from the 28 February 2011 valuation.

 

In October 2011, JZCP realized the sale of Document Holdings Corporation, the parent of Dantom Systems, Inc. Dantom was purchased in April 2005 as a platform to acquire and manage businesses that provide integrated services to third party debt collection agencies and to other consumer billing companies. The US$40.5 million JZCP received created a 4.8x multiple of equity invested, and a 27% IRR. We realized a US$5.4 million NAV increase from this sale, versus the 28 February 2011 valuation.

 

In November 2011, JZCP also realized US$83.0 million from the sale of its wound care businesses, Wound Care Holdings and Sechrist. The transaction represented a multiple of equity invested of 1.9x, and an IRR of 14%. Although JZCP had been writing up these investments over time, the sale still represented a US$7.3 million NAV increase.

 

In January 2012, we were repaid our US$29 million debt position in Continental Cement, a cement factory in central Missouri. We were paid in full with accrued interest.

 

During the year ended 29 February 2012 and post year end, JZCP sold 1,023,080 shares of TAL International Group, Inc ("TAL") in three secondary offerings realizing US$37.6 million. TAL has been a very successful investment, we plan to continue realizing our remaining share stake (357,418 of shares) in the next year.

 

Other Sectors

 

Over the past year, the bulk of our Mezzanine Portfolio has been re-paid due to the strength of the high yield debt market. We currently have two mezzanine investment of size, HAAS TCM, Inc., an automobile paint system supplier company. HAAS has been performing well, and paying cash interest per its terms.

 

Our largest mezzanine investment is TTS LLC ("TTS") (technical facilities for mechanical services), which is a US$15.2 million note. TTS is current on all interest and principal owed to us.

 

The only significant Legacy Portfolio investment left is Healthcare Products, our power wheelchair company. Despite the vicissitudes of dealing with Medicare, its primary customer, this company continues to perform to plan and we're hopeful of a successful exit above its valuation of US$22.7 million in our NAV.

 

Our Listed Equities declined with the market: TAL (the international container leasing company) and Safety Insurance (a Massachusetts based insurance company) together accounted for a reduction of per share NAV of 26 cents or US$17 million. During the year ended 29 February 2012 and post year end (as previously mentioned), we were able to sell 51% of our position in TAL in three successful secondary share offerings, for a US$27.3 million gain.

 

Our approach to credit opportunities (such as mezzanine loans) has always been based on our valuation of underlying business assets. Given the current dislocation in real estate related assets, we focused on funding interest bearing opportunities that meet our risk reward criteria i.e. the credit worthiness is supported by a conservative loan to value ratio.

 

We have begun to invest in secondary mortgage loans at a significant discount from par. These loans are being purchased with the help of experienced managers, directly from banks and government agencies such as the Federal Reserve.

 

Although we are just starting, we expect to be able to deploy US$50-100 million in high yielding paper with low loan to value ratios. These will produce a high current yield (above Treasuries and bank paper) and, depending on the discount, capital appreciation. We look forward to reporting more about this in the future.

 

In April 2012, we completed the purchase of almost an entire square block in Williamsburg, Brooklyn one of the fastest growing neighborhoods in New York City. We purchased over 100,000 square feet of retail units and forty apartments for approximately US$64 million. JZCP invested US$14.25 million in equity for a 75% ownership position.

 

Finally, in April 2012 we invested US$6.2 million in BSM Engenharia, a Brazil based infrastructure service business. BSM manages ports and other transportation focused infrastructure projects for businesses such as PertroBras, the nationally-owned oil company. Our 3.7% of BSM was purchased in conjunction with ACON, a very successful private equity group with significant Latin American experience. Given the exceptionally positive demographics in Brazil and certain other Latin American countries, we plan to look at other co-investment opportunities there in conjunction with other established private equity firms in the region.

 

Principal Risks and Uncertainties

 

As an investment fund, our principal risks are those that are associated with its investment portfolio. Given the nature of the portfolio, the principal risks are associated with the financial and operating performance of the underlying investments, along with market risk associated with the publicly listed equities.

 

Outlook

 

We believe the best way to achieve superior returns is by maintaining investment discipline and investing your (and our) money in a diversified portfolio of good quality niche businesses at reasonable prices. Our value oriented investment strategy has remained consistent through the years although the value-added/ operations management component has increased significantly. We are pleased to have excellent managers as partners and together we develop growth strategies and work on operational efficiencies for the respective portfolio companies. This approach to investing offers superior risk adjusted returns for our shareholders over the long-term.

 

We are making good progress in building out several of our investment verticals. The verticals will continue to be the growth engines for our NAV. We also think our co-investments with other private equity firms will provide great investment returns. Most importantly, our Company has never been more diversified and we will endeavor to continue to diversify by industry sector, asset class and to a lesser degree, geography, through our increasing exposure in Europe.

 

Furthermore, we expect our shareholders to benefit from the new dividend policy which will provide a more predictable level of distribution based on the Company's NAV. Most importantly, we will try not to lose any money along the way.

 

As always, thank you for your confidence in our investment strategy. Please feel free to contact us with any ideas that might be beneficial to JZCP.

 

Yours faithfully,

 

Jordan/Zalaznick Advisers, Inc.

 

17 May 2012

 

Investment Review

 

Company

 

JZCP

Book

cost*

US$'000

Historical Book

cost**

US$'000

Directors Valuation at

29 February

2012 US$'000

Carrying Value

Including

Accrued

Interest

29 February

2012

US$'000

Percentage of portfolio

%

 

Bank Debt First Lien Portfolio

 

KGB (formerly known as INFONXX, INC.) Worldwide provider of directory assistance

1,834

1,920

1,848

1,848

0.4

KINETEK, INC.*** Manufacturer of electric motors and gearboxes

3,955

4,299

4,245

4,245

0.8

WP EVENFLO HOLDINGS, INC. Manufacturer of children's products

119

139

135

135

-

Bank Debt: Second Lien Portfolio

DEKKO TECHNOLOGIES, LLC Distributor of electrical sub-components

11,418

11,368

12,862

12,971

2.6

KINETEK, INC.*** Manufacturer of electric motors and gearboxes

13,425

15,000

13,313

13,313

2.6

Total Bank Debt

30,751

32,726

32,403

32,512

6.4

Mezzanine Portfolio

GED HOLDINGS, INC. Manufacturer of windows

-

6,100

305

331

0.1

HAAS TCM GROUP, INC. Speciality chemical distribution

7,500

7,500

7,584

7,761

1.5

METPAR INDUSTRIES, INC. Manufacturer of restroom partitions

6,450

7,754

636

750

0.1

PETCO ANIMAL SUPPLIES, INC. Retailer of pet food, supplies and services

1,636

1,636

1,636

1,636

0.3

ROOFING SUPPLY GROUP, INC. Distributor of roofing products

131

1,406

3,961

3,967

0.8

TTS, LLC Provider of technical facilities for mechanical services

15,000

14,840

14,933

15,187

3.0

Total Mezzanine Porfolio

30,717

39,236

29,055

29,632

5.8

European Micro Cap Portfolio

EUROMICROCAP FUND 2010, LP Acquiror of Europe-based microcap companies

49,153

49,153

69,950

69,950

13.8

DOUCOUT, S.L. Provider of digitalisation, document processing and storage services

2,777

2,777

2,685

2,896

0.6

GRUPO OMBUDS Provider of personal security and asset protection

12,202

12,202

11,353

12,283

2.4

Total European Micro Cap Portfolio

64,132

64,132

83,988

85,129

16.8

 

US Micro Cap Portfolio

ACCUTEST HOLDINGS, INC. Provision of environmental testing laboratories to the US market

34,978

31,516

38,325

39,090

7.6

BG HOLDINGS, INC. Manufacturer of industrial gears

19,733

19,733

28,206

28,735

5.7

CHINA DENTAL HOLDINGS, INC. Acquiror of China-based dental labratories

1,126

1,126

1,252

1,273

0.3

DENTAL SERVICES, INC. Operator of dental laboratories

33,367

27,604

23,318

24,060

4.7

IND SERVICES SOLUTIONS (ISS#2) Acquiror of industrial equipment service businesses. Its first acquisition was Southern Parts & Engineering Co., a supplier of industrial compressor parts and services

7,374

7,374

7,580

7,706

1.5

JZ PALATINE CO-INVESTMENT, LLC . Invests in distressed debt

764

764

764

764

0.2

MILESTONE AVIATION GROUP, INC. Finance provider for helicopter and private jet owners

10,774

10,774

11,288

11,454

2.3

NATIONWIDE STUDIOS, INC. Processer of digital photos for preschoolers

16,132

16,132

4,052

4,200

0.8

NEW VITALITY HOLDINGS, INC. Direct-to-consumer provider of nutritional supplements and personal care products

4,000

4,000

4,483

4,604

0.8

SAFETY PRODUCTS, INC. Acquiror of safety product companies. Its first acquisition was Justrite, a manufacturer of industrial safety products.

4,428

4,428

4,587

4,641

0.9

SALTER LABS, INC. Developer and manufacturer of respiratory medical products and equipment for the homecare, hospital, and sleep disorder markets

19,163

19,163

11,707

11,956

2.4

SENSORS SOLUTIONS, INC. Acquiror of businesses affiliated with sensor devices or systems. Acquisitions have included Nielsen-Kellerman and Amptek, Inc.

25,285

25,285

25,633

25,994

5.1

TAP HOLDINGS, INC. Acquiror of food product manufacturers or distributors

575

575

659

669

0.1

TESTING SERVICES HOLDINGS Acquiror of laboratory testing businesses. Its first acquisition was Galson Holdings, Inc., a provider of industrial hygiene testing services

2,883

2,883

8,511

8,567

1.7

TRIWATER HOLDINGS CORPORATION Acquiror of water treatment businesses. Its first acquisition was Nashville Chemical & Equipment Co., a provide of water treatment supplies and services

7,402

7,402

7,716

7,844

1.5

US SANITATION, LLC Acquiror of janitorial and sanitorial product distributors and related chemical manufacturers and blenders.

97

97

97

98

0.0

Total US Micro Cap Portfolio

188,081

178,856

178,178

181,655

35.6

 

Legacy Portfolio:

ETX HOLDINGS, INC. Provider of services to the auto after sales market

392

392

602

613

0.1

HEALTHCARE PRODUCTS HOLDINGS, INC.

Designer and manufacturer of motorised vehicles

13,848

17,636

21,578

22,727

4.5

JORDAN INDUSTRIES, INC. Conglomerate

-

21

-

-

0.0

JZ INTERNATIONAL, LLC Fund of European LBO investments

1,620

660

1,620

1,620

0.3

NTT ACQUISITION CORP. Technical education and training

52

946

52

52

0.0

TIGER INFORMATION SYSTEMS, INC. Provider of temporary staff and computer training

300

400

300

300

0.1

Total Legacy Portfolio

16,212

20,055

24,152

25,312

5.0

Listed Investments

Equities

SAFETY INSURANCE GROUP, INC. Provider of automobile insurance

42,223

6,816

49,363

49,363

9.7

TAL INTERNATIONAL GROUP, INC.*** Lessor of intermodal shipping containers

24,671

10,652

38,409

38,409

7.6

UNIVERSAL TECHNICAL INSTITUTE, INC.

Vocational training in the automotive and marine fields

835

15

867

867

0.2

Total Listed Equity Investments

67,729

17,483

88,639

88,639

17.5

UK Gilts

UK treasury 2% - maturity 22/01/2016

32,431

32,431

33,397

33,465

6.6

Total UK Gilts

32,431

32,431

33,397

33,465

6.6

Corporate Bonds

HSBC Finance Corp, 06/01/16

13,709

13,709

13,489

13,525

2.7

JP Morgan Chase Bank NA, 06/13/16

9,273

9,273

9,257

9,276

1.8

Wachovia Bank NA, 03/15/16

9,435

9,435

9,309

9,328

1.8

Total Corporate Bonds

32,417

32,417

32,055

32,129

6.3

Total - Portfolio

462,470

417,336

501,867

508,473

100.0

Zero Dividend Preference shares

(87,281)

Cash and other net assets

194,270

Net assets attributable to Ordinary shares

615,462

 

* Book cost to JZCP equating to transfer value as at 1 July 2008 upon the liquidation of JZEP and adjusted for subsequent transactions. The book cost excludes the transfer value and subsequent Payment In Kind ("PIK") investments.

**Original book cost incurred by JZEP/JZCP adjusted for subsequent transactions. The book cost represents cash outflows and excludes PIK investments.

*** Invested in deals with the Resolute Fund - see note 29.

Mezzanine Portfolio includes common stock with a carrying value of US$5,471,000 and preferred shares with a carrying value of US$187,000 these investments are classified as Investments at fair value through profit or loss.

Legacy Portfolio - Investments not subject to capital incentive fee. The listed equities Safety Insurance Group, Inc and Universal Technical Institute, Inc. are also classified as legacy investments for the purpose of calculating the incentive fees payable to the Investment Adviser.

 

Investment Review - Major Holdings

 

 

The investments listed represent the top ten investments in terms of valuation:

 

EuroMicrocap Fund 2010, LP

 

Headquarters: London, UK

Sector: Acquiror of Europe-based microcap companies

 

Euro MicroCap Fund 2010, LP is a private equity fund built around the investment team at JZ International, the European private equity platform founded in 1999 with Jock Green-Armytage, the former chairman of JZEP. The fund's aim is to make investments in Europe-based micro cap companies.

 

 

 

 

Historical Book

cost*

US$'000

Directors'

Valuation at

29 February 2012

US$'000

LP interest

49,153

69,950

49,153

69,950

 

SAFETY INSURANCE GROUP, INC.

 

Headquarters: Boston, Massachusetts, USA

Sector: Property and Casualty Insurance

 

Safety Insurance Group, Inc., which is listed on NASDAQ (NASDAQ: SAFT), provides personal property and casualty insurance focused exclusively on the Massachusetts market. The Company's principal product line is private passenger automobile insurance. In addition, Safety Insurance offers commercial automobile, homeowners, dwelling fire, umbrella and business owning policies.

 

 

 

 

Historical Book

cost*

US$'000

Directors'

Valuation at

29 February 2012

US$'000

Common stock

6,816

49,363

Year ended 31 December 2011 Sales

US$660.2m

Year ended 31 December 2011 Adjusted EBITDA

US$27.9m

 

 

ACCUTEST HOLDINGS, INC.

 

Headquarters: Dalton, New Jersey, USA

Sector: Environmental Testing Laboratories

 

Accutest Laboratories is a full service, independent testing laboratory successfully delivering legally defensive data for more than 50 years. Founded in 1956, they provide a full range of water, soil and air testing services to industrial, engineering/consulting and government clients throughout the United States.

 

 

 

 

Historical Book

cost*

US$'000

Directors'

Valuation at

29 February 2012

US$'000

12.5% Senior Subordinated Notes

7,425

8,330

10% Preferred Stock

24,052

29,995

Common stock with an equity interest of 38.7%

39

-

31,516

38,325

Year ended 31 December 2011 Sales

US$79.9m

Year ended 31 December 2011 Adjusted EBITDA

US$12.8m

 

TAL INTERNATIONAL GROUP, INC

 

Headquarters: Purchase, New York , USA

Sector: Industrial Transportation

 

TAL International Group, Inc., which is listed on the New York Stock Exchange (NYSE: TAL), is one of the world's largest lessors of intermodal shipping containers with a fleet of over 945,000 standard dry freight, refrigerated and special containers which are serviced out of 225 container depots in 39 countries. The company's customers include shipping companies, distribution companies, manufacturers and transport companies.

 

 

 

 

Historical Book

cost*

US$'000

Directors'

Valuation at

29 February 2012

US$'000

Common stock

10,652

38,409

Year ended 31 December 2011 Sales

US$516.7m

Year ended 31 December 2011 Adjusted EBITDA

US$492.2m

 

BG HOLDINGS INC.

 

Headquarters: Cleveland, Ohio, USA

Sector: Industrial Gears

 

BG Holdings Inc owns The Horsburgh & Scott Co ("H&S") and Mid-American Machine & Equipment Co ("MAM"). H&S is a privately held manufacturer of highly engineered industrial gears and mechanical gear drives, with a market leading position in the large-diameter gear market. Founded in 1886, H&S offers a wide array of large gear types and engineering services for new or replacement installations, as well as custom industrial gears, repair, spare parts, heat treatment and other technical solutions. H&S also provides field service for its customers. H&S' products are used in a variety of applications in steel, mining, sugar, aluminium, and power generation among other industries. MAM is a provider of service, repair and equipment refurbishments primarily to the tyre and rubber industry.

 

 

Historical Book

cost*

US$'000

Directors'

Valuation at

29 February 2012

US$'000

12.5% Senior Subordinated Notes

2,624

3,200

Preferred Stock

17,031

24,969

Common stock with an equity interest of 37.3%

78

37

19,733

28,206

Year ended 31 December 2011 Sales

US$75.8m

Year ended 31 December 2011 Adjusted EBITDA

US$12.7m

 

 

DENTAL HOLDINGS CORPORATION

 

Headquarters: Minneapolis, Minnesota, USA

Sector: Healthcare Equipment and Services

 

Dental Holdings Corporation is the parent of Dental Services Group ("DSG"). DSG is an operator of laboratories which manufacture oral appliances for dentists and dental centres. It runs both full service labs and "sale and delivery" sites in the United States, Canada and Mexico, making it one of the largest companies of its kind.

 

 

 

 

Historical Book

cost*

US$'000

Directors'

Valuation at

29 February 2012

US$'000

15% Senior Notes

7,500

8,667

15% Subordinated Notes

250

298

12.5% Senior Notes

8,154

10,437

8% Preferred Stock

6,713

3,916

10% Preferred Stock

4,950

-

Common stock with an equity interest of 35.4%

37

-

27,604

23,318

Year ended 31 December 2011 Sales

US$72.7m

Year ended 31 December 2011 Adjusted EBITDA

US$1.5m

 

HEALTHCARE PRODUCTS HOLDINGS, INC.

 

Headquarters: Sarasota, Florida, USA

Sector: Healthcare Services & Equipment

 

Healthcare Products Holdings, Inc's operating subsidiary is Hoveround Corporation, a designer, manufacturer and distributor of motorised wheelchairs and other patented mobility vehicles. Hoveround Corporation utilizes a direct-to-the-customer marketing concept to sell and deliver its products.

 

 

 

 

Historical Book

cost**

US$'000

Directors'

Valuation at

29 February 2012

US$'000

12.5% Second Lien Notes

3,250

9,519

12% Subordinated Notes

8,149

8,149

14% Subordinated Notes

2,450

3,910

6% Preferred Stock

3,550

-

Common stock with an equity interest of 2%

237

-

17,636

21,578

Year ended 31 December 2011 Sales

US$96.6m

Year ended 31 December 2011 Adjusted EBITDA

US$7.6m

 

SENSORS SOLUTIONS, INC.

 

Headquarters: Bedford, Massachusetts, USA and Boothwyn, PA

Sector: Sensors & Instrumentation

 

Sensors Solutions is the parent company of Nieilsen-Kellerman and Amptek, Inc. Nieilsen-Kellerman, located in Boothwyn, PA, is a producer of weather measurement devices. Amptek, Inc., located in Bedford, MA, designs and manufacturers instrumentation used in numerous non-destructive testing and elemental analysis applications.

 

 

 

 

Historical Book

cost*

US$'000

Directors'

Valuation at

29 February 2012

US$'000

9% Senior Notes

9,000

9,000

10% Preferred Stock

2,517

2,784

10% Preferred Stock

369

411

7% Preferred Stock

13,362

13,401

Common stock

37

37

25,285

25,633

Year ended 31 December 2011 Sales

US$45.1m

Year ended 31 December 2011 Adjusted EBITDA

US$17.7m

 

TTS, LLC

 

Headquarters: Denver, Colorado, USA

Sector: Commercial services

 

TTS, LLC is the parent company of MSCH, Inc. MSCH, Inc. provides integrated energy efficiency services and contractural maintenance programs for heating, ventilation and air conditioning ("HVAC") systems, chilled water systems and building automation and controls.

 

 

 

 

Historical Book

cost*

US$'000

Directors'

Valuation at

29 February 2012

US$'000

12.5% Senior Subordinated Notes

14,840

14,933

14,840

14,933

Year ended 31 December 2011 Sales

US$140.9m

Year ended 31 December 2011 Adjusted EBITDA

US$15.0m

 

KINETEK, INC.

 

Headquarters: Deerfield, Illinois, USA

Sector: Industrial Manufacturing

 

Kinetek, Inc. Is a provider of custom engineered control, monitor and drive system solutions for customers in the elevator/escalator, commercial floor care, material handling/aerial lift, commercial food equipment, renewable energy and medical markets.

 

 

 

Historical Book

cost*

US$'000

Directors'

Valuation at

29 February 2012

US$'000

Bank debt - First Lien

4,299

4,245

Bank debt - Second Lien

15,000

13,313

19,299

17,558

Year ended 31 December 2011 Sales

US$400.2m

Year ended 31 December 2011 Adjusted EBITDA

US$48.0m

 

*Original book cost incurred by JZEP/JZCP adjusted for subsequent transactions. The book cost represents the cash outflow and excludes the notional cost of PIK investments.

 

Independent Auditors' Report

 

Independent auditors' report to the members of JZ Capital Partners Limited

 

We have audited the financial statements of JZ Capital Partners Limited for the year ended 29 February 2012 which comprise the Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, Statement of Cash Flows and the related Notes 1 to 32. The financial reporting framework that has been applied in their preparation is applicable law and International Financial Reporting Standards as adopted by the European Union.

 

This report is made solely to the Company's members, as a body, in accordance with Section 262 of the Companies (Guernsey) Law, 2008. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body, for our audit work, for this report, or for the opinions we have formed.

 

Respective Responsibilities of Directors and Auditors

As explained more fully in the Statement of Directors' Responsibilities in the Report of the Directors, the Directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors.

 

Scope of the Audit of the Financial Statements

An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the Company's circumstances and have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by the Directors; and the overall presentation of the financial statements. In addition, we read all the financial and non-financial information in the Annual Report for the year ended 29 February 2012 to identify material inconsistencies with the audited financial statements. If we become aware of any apparent material misstatements or inconsistencies we consider the implications for our report

 

Opinion

In our opinion the financial statements:

 

• give a true and fair view of the state of the Company's affairs as at 29 February 2012 and of its profit for the year then ended;

• have been properly prepared in accordance with International Financial Reporting Standards as adopted by the European Union; and

• have been prepared in accordance with the requirements of the Companies (Guernsey) Law, 2008.

 

Matters on Which We Are Required to Report by Exception

We have nothing to report in respect of the following matters where the Companies (Guernsey) Law, 2008 require us to report to you if, in our opinion:

 

• proper accounting records have not been kept; or

• the financial statements are not in agreement with the accounting records; or

• we have not received all the information and explanations we require for our audit.

 

Under the Listing Rules we are required to review the part of the Corporate Governance Statement relating to the Company's compliance with the nine provisions of the UK Corporate Governance Code specified for our review.

 

Michael Bane

for and on behalf of Ernst & Young LLP

Guernsey, Channel Islands

 

17 May 2012

 

Notes:

 

1. The maintenance and integrity of the JZ Capital Partners Limited website is the responsibility of the Directors; the work carried out by the auditor does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the financial statements since they were initially presented on the website. Legislation in Guernsey governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions

 

Statement of Comprehensive Income

 

For the year ended 29 February 2012

 

Year ended 29 February 2012

Year ended 28 February 2011

Revenue

Capital

Total

Revenue

Capital

Total

Notes

return

return

return

return

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

Income

Net gain on investments at fair value through profit or loss

 

 

5

 

 

-

 

 

7,054

 

 

7,054

 

 

-

 

 

119,628

 

 

119,628

Net write back of impairments/(impairments) on loans and receivables

 

 

6

 

 

-

 

 

142

 

 

142

 

 

-

 

 

(2,019)

 

 

(2,019)

Share of associate's net income

 

11

 

-

 

20,797

 

20,797

 

-

 

-

 

-

Realisations from investments held in escrow

 accounts

 

 

 

 

-

 

 

2,093

 

 

2,093

 

 

-

 

 

2,553

 

 

2,553

Net foreign currency exchange gains/(losses)

 

 

 

-

 

1,694

 

1,694

 

-

 

(5,008)

 

(5,008)

Investment income

7

43,558

-

43,558

41,228

-

41,228

Bank and deposit interest

460

-

460

343

-

343

44,018

31,780

75,798

41,571

115,154

156,725

Expenses

Investment Adviser's base fee

 

9

 

(10,247)

 

-

 

(10,247)

 

(8,667)

 

-

 

(8,667)

Investment Adviser's capital incentive fee

 

9

 

-

 

(5,357)

 

(5,357)

 

-

 

(2,093)

 

(2,093)

Investment Adviser's income incentive fee

 

9,29

 

(4,410)

 

-

 

(4,410)

 

-

 

-

 

-

Administrative expenses

9

(2,786)

-

(2,786)

(2,094)

-

(2,094)

(17,443)

(5,357)

(22,800)

(10,761)

(2,093)

(12,854)

Operating profit

26,575

26,423

52,998

30,810

113,061

143,871

Finance costs

Finance costs in respect of Zero Dividend Preference shares

 

 

8

 

 

-

 

 

(6,581)

 

 

(6,581)

 

 

-

 

 

(5,938)

 

 

(5,938)

Profit before taxation

26,575

19,842

46,417

30,810

107,123

137,933

Withholding Taxes

10

(1,373)

-

(1,373)

(690)

-

(690)

Profit for the year

25,202

19,842

45,044

30,120

107,123

137,243

Weighted average number of Ordinary shares in issue during year

 

 

23

 

 

65,018,610

 

 

65,018,610

Basic and diluted profit per Ordinary share using the weighted average number of Ordinary shares in issue during the year

 

 

 

 

38.76c

 

 

 

 

30.52c

 

 

 

 

69.28c

 

 

 

 

46.33c

 

 

 

 

164.75c

 

 

 

 

211.08c

 

All items in the above statement are derived from continuing operations.

The profit for the year is attributable to the Ordinary shareholders of the Company.

The format of the Income Statement follows the recommendations of the AIC Statement of Recommended Practice.

 

Statement of Financial Position

 

As at 29 February 2012

 

 

29 February

28 February

2012

2011

Notes

US$'000

US$'000

Assets

Investments at fair value through profit or loss

11

414,549

447,804

Investments classified as loans and receivables

11

23,974

45,952

Investment in an associate

11

69,950

-

Cash held on deposit

12

7,968

-

Other receivables

14

451

464

Cash and cash equivalents

13

194,513

172,267

Total assets

711,405

666,487

Liabilities

Zero Dividend Preference shares

16

87,281

82,341

Other payables

15

8,662

3,358

Total liabilities

95,943

85,699

Equity

19

Share capital account

149,269

149,269

Distributable reserve

353,528

353,528

Capital reserve

41,775

21,933

Revenue reserve

70,890

56,058

Total equity

615,462

580,788

Total liabilities and equity

711,405

666,487

Number of Ordinary shares in issue at year end

17

65,018,610

65,018,610

Net asset value per Ordinary share

24

US$ 9.47

US$ 8.93

 

These audited financial statements were approved by the Board of Directors and authorised for issue on 17 May 2012. They were signed on its behalf by:

 

David Macfarlane Patrick Firth

Chairman Director

 

Statement of changes in equity

 

 

For the year ended 29 February 2012

 

Share

Capital

Distributable

Capital Reserve

Revenue

 

Notes

Account

US$'000

Reserve

US$'000

Realised

US$'000

Unrealised

US$'000

Reserve

US$'000

Total

US$'000

Balance at 1 March 2011*

149,269

353,528

14,525

7,408

56,058

580,788

Profit for the year

-

-

53,582

(33,740)

25,202

45,044

Dividends paid

30

-

-

-

-

(10,370)

(10,370)

Balance at 29 February 2012

 

149,269

 

353,528

 

68,107

 

(26,332)

 

70,890

 

615,462

 

\* The opening balances at 1 March 2011 have been adjusted to reflect the reallocation of ZDP interest totalling US$9,826,000, from realised capital to unrealised capital reserves.

 

For the year ended 28 February 2011

 

Share

Capital

Distributable

Capital Reserve

Revenue

Account

US$'000

Reserve

US$'000

Realised

US$'000

Unrealised

US$'000

Reserve

US$'000

Total

US$'000

Balance at 1 March 2010

149,269

353,517

(20,617)

(64,573)

39,917

457,513

Profit for the year

-

-

25,316

81,807

30,120

137,243

Dividends paid

-

-

-

-

(13,979)

(13,979)

Increase in receivables relating to JZ Equity Partners Plc

 

-

 

11

 

-

 

-

 

-

 

11

Balance at 28 February 2011

149,269

353,528

4,699

17,234

56,058

580,788

 

Statement of cash flows

 

For the year ended 29 February 2012

 

 

1 March 2011 to

 29 February 2012

1 March 2010 to

 28 February 2011

Notes

US$'000

US$'000

Operating activities

Net cash inflow from operating activities

25

1,633

15,056

Cash outflow for purchase of investments

(73,729)

(115,814)

Cash outflow for purchase of treasury and floating notes

 

(64,293)

 

(99,695)

Cash outflow for deposits with maturity date greater than 3 months

 

(7,901)

 

-

Cash outflow from capital calls in associate

(49,153)

 

-

Cash inflow from repayment and disposal of investments

 

226,059

 

150,694

Cash inflow from sale of US treasury notes

-

101,133

Net cash inflow before financing activities

32,616

51,374

Financing activity

Issue costs relating to the issue of Ordinary shares

-

(297)

Receipt of liquidation funds from JZEP

-

302

Distributions paid to shareholders

(10,370)

(13,979)

Net cash outflow from financing activities

(10,370)

(13,974)

Increase in cash and cash equivalents

22,246

37,400

Reconciliation of net cash flow to movements in cash and cash equivalents

Cash and cash equivalents at 1 March

172,267

134,867

Increase in cash and cash equivalents as above

22,246

37,400

Cash and cash equivalents at year end

194,513

172,267

 

The accompanying notes form an integral part of the financial statements.

 

Notes to the Financial Statements

 

1. General Information

JZ Capital Partners Limited (the "Company") is a Guernsey domiciled closed-ended investment company which was incorporated in Guernsey on 14 April 2008 under The Companies (Guernsey) Law, 1994. The Company is now subject to the Companies (Guernsey) Law, 2008. The Company's Share Capital consists of Ordinary shares, Limited Voting

 

Ordinary shares ("LVO") and Zero Dividend Preference ("ZDP") shares. The Ordinary shares and ZDP shares were admitted to the official list of the London Stock Exchange on 1 July 2008. The LVO shares are not listed and are not admitted to trade on or through the facilities of the London Stock Exchange.

 

The Company was granted consent on 8 May 2008 by the Guernsey Financial Services Commission under The Control of Borrowing (Bailiwick of Guernsey) Ordinance,1959 to raise up to £300,000,000 by the issue of shares.

 

The Company was launched in connection with a scheme of reconstruction and voluntary winding up of JZ Equity Partners Plc ("JZEP") under section 110 of the Insolvency Act 1986. JZEP's assets, after providing for its liabilities were transferred in specie to the Company on 1 July 2008 and the Company issued to JZEP Shareholders (other than those who opted against the new scheme) one Ordinary Share for each JZEP Ordinary share and one Zero Dividend Preference ("ZDP") share for each JZEP ZDP share that they held.

 

LVO shares were issued so that certain of the Company's existing Shareholders and certain new investors that are Qualifying US Persons could participate in the Ordinary share Issue without causing the Company to be treated as a US domestic company for the purposes of US securities laws and/or a CFC for US tax purposes. LVO shares are identical to, and rank pari passu in all respects with, the New Ordinary shares except that the LVO Shares will only carry a limited entitlement to vote in respect of the appointment or removal of Directors and will not carry any entitlement to vote in respect of certain other matters.

 

The Company is classed as an authorised fund under the Protection of Investors (Bailiwick of Guernsey) Law 1987.

 

The Company's corporate objective is to create a portfolio of investments in businesses primarily in the United States, but also in Europe, providing a superior overall return comprised of a current yield and significant capital appreciation.

 

The Company's present strategies include investments in micro-cap buyouts, mezzanine loans (sometimes with equity participations) and high yield securities, senior secured debt and second lien loans and other debt and equity opportunities, including distressed debt and structured financings, derivatives and opportunistic purchase of publicly traded securities.

 

The Company has no direct employees. For its services the Investment Adviser receives a management fee and is also entitled to a performance-related fee (note 9). The Company has no ownership interest in the Investment Adviser. The Company is administered by Butterfield Fulcrum Group (Guernsey) Limited (note 9).

 

The financial statements are presented in US$'000 except where otherwise indicated.

 

2. Significant Accounting Policies

The accounting policies adopted in the preparation of these financial statements have been consistently applied during the period, unless otherwise stated

 

Statement of Compliance

The financial statements have been prepared in accordance with International Financial Reporting Standards as adopted by the European Union ("IFRS"), which comprise standards and interpretations approved by the International Accounting Standards Board ("IASB") and International Accounting Standards ("IAS") and Standing Interpretations approved by the International Accounting Standards Committee ("IASC") that remain in effect, and have been adopted by the European Union, together with applicable legal and regulatory requirements of Guernsey Law and the Listing Rules of the London Stock Exchange.

 

Basis of preparation

The financial statements have been prepared under the historical cost or amortised cost basis, modified by the revaluation of financial instruments designated at fair value through profit or loss upon initial recognition. The principal accounting policies adopted are set out below. The preparation of financial statements in conformity with IFRS requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The financial statements follow the Association of Investment Companies ("AIC") Statement of Recommended Practice ("SORP") issued on 21 January 2009.

 

Going concern

A fundamental principle of the preparation of financial statements in accordance with IFRS is the assumption that an entity will continue in existence as a going concern, which contemplates continuity of operations and the realisation of assets and settlement of liabilities occurring in the ordinary course of business.

 

The Directors consider the Company has adequate financial resources, in view of its holding in cash and cash equivalents and liquid investments and the income streams deriving from its investments and believe that the Company is well placed to manage its business risks successfully to continue in operational existence for the foreseeable future and that it is appropriate to prepare the financial statements on the going concern basis.

 

Changes in accounting policy and disclosures

The accounting policies adopted are consistent with those of the previous financial period except as follows:

 

The Company has adopted the following standards and amendments as of 1 March 2011, although they had no effect on the financial statements:

 

IAS 24 Related Party Disclosures (amendment) effective 1 January 2011

The IASB issued an amendment to IAS 24 that clarifies the definitions of a related party.

 

IAS 32 Financial Instruments: Presentation (amendment) effective 1 February 2010.

The IASB issued an amendment that alters the definition of a financial liability in IAS 32 to enable entities to classify rights issues and certain options or warrants as equity instruments.

 

IFRIC 19 Extinguishing Financial Liabilities with Equity Instruments effective 1 July 2010

The interpretation clarifies that equity instruments issued to a creditor to extinguish a financial liability qualify as consideration paid.

 

Improvements to IFRSs (May 2010) effective either 1 July 2010 or 1 January 2011.

In May 2010, the IASB issued its third omnibus of amendments to its standards, primarily with a view to removing inconsistencies and clarifying wording.

 

The following standards, amendments and interpretations are not effective and are not expected to have material impact on the financial position or performance of the Company:

 

IAS 27 Separate Financial Statements (as revised in 2011)

As a consequence of the new IFRS 10 and IFRS 12, what remains of IAS 27 is limited to accounting for subsidiaries, jointly controlled entities, and associates in separate financial statements. The Company does not present separate financial statements. The amendment becomes effective for annual periods beginning on or after 1 January 2013.

 

IAS 28 Investments in Associates and Joint Ventures (as revised in 2011)

As a consequence of the new IFRS 11 and IFRS 12, IAS 28 has been renamed IAS 28 Investments in Associates

and Joint Ventures, and describes the application of the equity method to investments in joint ventures in addition to associates. The amendment becomes effective for annual periods beginning on or after 1 January 2013.

 

IFRS 7 Financial Instruments: Disclosures - Enhanced Derecognition Disclosure Requirements

The amendment requires additional disclosure about financial assets that have been transferred but not derecognised to enable the user of the Company's financial statements to understand the relationship with those assets that have not been derecognised and their associated liabilities. In addition, the amendment requires disclosures about continuing involvement in derecognised assets to enable the user to evaluate the nature of, and risks associated with, the entity's continuing involvement in those derecognised assets. The amendment becomes effective for annual periods beginning on or after 1 July 2011. The amendment affects disclosure only and has no impact on the Group's financial position or performance.

 

IFRS 9 Financial Instruments: Classification and Measurement

The adoption of the first phase of IFRS 9 (effective for periods beginning on after 1 January 2015) will have an effect on the classification and measurement of the Company's financial assets, but will potentially have no impact on classification and measurements of financial liabilities.

 

IFRS 10 Consolidated Financial Statements

IFRS 10 establishes a single control model that applies to all entities including special purpose entities. The changes introduced by IFRS 10 will require management to exercise significant judgement to determine which entities are controlled, and therefore, are required to be consolidated by a parent.

 

IFRS 12 Disclosure of Involvement with Other Entities

IFRS 12 includes all of the disclosures that were previously in IAS 27 related to consolidated financial statements, as well as all of the disclosures that were previously included in IAS 31 and IAS 28. These disclosures relate to an entity's interests in subsidiaries, joint arrangements, associates and structured entities. A number of new disclosures are also required. This standard becomes effective for annual periods beginning on or after 1 January 2013.

 

IFRS 13 Fair Value Measurement

IFRS 13 establishes a single source of guidance under IFRS for all fair value measurements. IFRS 13 does not change when an entity is required to use fair value, but rather provides guidance on how to measure fair value under IFRS when fair value is required or permitted. The Company is currently assessing the impact that this standard will have on the financial position and performance. This standard becomes effective for annual periods beginning on or after 1 January 2013.

 

There are certain other current standards, amendments and interpretations that are not relevant to the Company's operations.

 

Functional and presentational currency

Items included in the financial statements of the Company are measured in the currency of the primary economic environment in which the Company operates ("the functional currency"). The functional currency of the Company as determined in accordance with IFRS is the

 

US dollar because this is the currency that best reflects the economic substance of the underlying events and circumstances of the Company. The financial statements are presented in US dollars, as the Company has chosen the US dollar as its presentation currency.

 

Foreign exchange

Monetary assets and liabilities denominated in foreign currency are translated into the functional currency at the rate of exchange ruling at the end of the reporting period date. Transactions in foreign currencies during the course of the period are translated at the rate of exchange ruling at the date of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at reporting period end exchange rates of monetary assets and liabilities and non-monetary assets and liabilities that are denominated in foreign currencies are recognised in the statement of comprehensive income. Foreign exchange gains and losses on financial assets and financial liabilities at fair value through profit or loss are recognised together with other changes in the fair value. Net foreign exchange gains or losses on monetary financial assets and liabilities other than those classified as at fair value through profit or loss are included in the line item "Net foreign currency exchange gains/(losses)".

 

Financial assets and financial liabilities

(a) Financial assets and liabilities at fair value through profit or loss

 

(i) Classification

The Company classifies its investments in listed investments, investments in first and second lien debt securities, other equity opportunities and other investments within its Micro Cap and Legacy portfolios as financial assets at fair value through profit or loss. These financial assets are designated by the Board of Directors as at fair value through profit or loss at inception.

 

Financial assets and financial liabilities designated at fair value through profit or loss at inception are those that are managed and their performance evaluated on a fair value basis in accordance with the Company's investment strategy as documented in its prospectus. Information about these financial assets and financial liabilities are evaluated by the management of the Company on a fair value basis together with other relevant financial information.

 

(ii) Recognition/derecognition

Purchases and sales of investments are recognised on the trade date - the date on which the Company commits to purchase or sell the investment. Investments are derecognised when the rights to receive cash flows from the investments have expired or the Company has transferred substantially all risks and rewards of ownership.

 

Financial assets and liabilities at fair value through profit or loss are initially recognised at fair value. Transaction costs are expensed in the statement of comprehensive income.

 

Subsequent to initial recognition, all financial assets and liabilities at fair value through profit or loss are measured at fair value. Gains and losses arising from changes in the fair value of the "financial assets or financial liabilities at fair value through profit or loss" category are presented in the statement of comprehensive income in the period in which they arise.

 

Dividend income from financial assets at fair value through profit or loss is recognised in the statement of comprehensive income within investment income when the Company's right to receive payment is established.

 

Realised surpluses and deficits on the partial sale of investments are arrived at by deducting the average cost of such investments from the sales proceeds.

 

(iii) Fair value estimation

The fair value of financial instruments traded in active markets (such as publicly traded securities) is based on quoted market prices at the balance sheet date. The quoted market price used for financial assets held by the Company is the bid price.

 

Unquoted preferred shares, micro cap loans, unquoted equities and equity related securities investments are typically valued by reference to their enterprise value, which is generally calculated by applying an appropriate multiple to the last twelve months' earnings before interest, tax, depreciation and amortisation ("EBITDA"). In determining the multiple, the Directors consider inter alia, where practical, the multiples used in recent transactions in comparable unquoted companies, previous valuation multiples used and where appropriate, multiples of comparable publicly traded companies. In accordance with IPEVCA guidelines, a marketability discount is applied which reflects the discount that in the opinion of the Directors, market participants would apply in a transaction in the investment in question.

 

Traded loans including first and second lien term securities are valued by reference to the last indicative bid price from recognised market makers. These investments are classified in the Statement of Financial Position as Investments at fair value through profit or loss.

 

(b) Loans and receivables

 

(i) Classification

The Company classifies unquoted senior subordinated debt within Mezzanine investments as loans and receivables.

 

Investments are generally accounted for at amortised cost using the effective interest method except where there is deemed to be impairment in value which indicates that a provision should be made.

 

(ii) Recognition/derecognition

Purchases and sales of investments are recognised on the trade date - the date on which the Company commits to purchase or sell the investment. Investments are derecognised when the rights to receive cash flows from the investments have expired or the Company has transferred substantially all risks and rewards of ownership.

 

(iii) Measurement

The effective interest method is a method of calculating the amortised cost of a financial asset or a financial liability and of allocating the interest income or interest expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash payments or receipts through the expected life of the financial instrument or, when appropriate, a shorter period to the net carrying amount of the financial asset or financial liability. When calculating the effective interest rate, the Company estimates cash flows considering all contractual terms of the financial instrument but does not consider future credit losses. The calculation includes all fees paid or received between parties to the contract that are an integral part of the effective interest rate, transaction costs and all other premiums or discounts.

 

(iv) Impairment

The Company assesses at each reporting date whether the loans and receivables are impaired. Evidence of impairment may include indications that the counterparty is experiencing significant financial difficulty, default or delinquency in interest or principal payments, the probability that they will enter bankruptcy or other financial reorganisation and where observable data indicate that there is a measurable decrease in the estimated future cash flows, such as changes in arrears or economic conditions that correlate with defaults.

 

If there is objective evidence that an impairment loss has occurred, the amount of the loss is measured as the difference between the asset's carrying amount and the net present value of expected cash flows discounted at the original effective interest rate.

 

The carrying amount of the asset is reduced through the use of an allowance account and the amount of the loss is recognised in the statement of comprehensive income as net impairments on loans and receivables.

 

Impaired debts together with the associated allowance are written off when there is no realistic prospect of future recovery and all collateral has been realised or has been transferred to the Company. If, in a subsequent period, the amount of the estimated impairment loss increases or decreases because of an event occurring after the impairment was recognised, the previously recognised impairment loss is increased or reduced by adjusting the allowance account. If a previous write-off is later recovered, the recovery is credited to net impairments/write back of impairments on loans and receivables.

 

(c) Investment in an associate

The Company's investment in its associate is accounted for using the equity method. An associate is an entity in which the Company has significant influence. An entity is regarded as a subsidiary only if the Company has control over its strategic, operating and financial policies and intends to hold the investment on a long-term basis for the purpose of securing a contribution to the Company's activities.

 

The Directors have determined that although the Company has over 50% economic partnership interest in Euromicrocap Fund 2010, LP (the "Partnership"), it does not have the power to govern the financial and operating policies of the partnership. Such powers are vested with the General Partner. However the Company does have significant influence over the partnership.

 

Under the equity method, the investment in the associate is carried in the statement of financial position at cost plus post acquisition changes in the Company's share of net assets of the associate. The income statement reflects the share of the results of operations of the associate. Where there has been a change recognised directly in the equity of the associate, the Company recognises its share of any changes and discloses this, when applicable, in the statement of changes in equity. Unrealised gains and losses resulting from transactions between the Company and the associate are eliminated to the extent of the interest in the associate. The share of profit of an associate is shown on the face of the income statement. This is the profit attributed to holders of partnership interest in the associate.

 

After application of the equity method, the Company determines whether it is necessary to recognise an additional impairment loss on the Company's investment in its associate. The Company determines at each reporting date whether there is any objective evidence that the investment in the associate is impaired. If this is the case the Company calculates the amount of impairment as the difference between the recoverable amount of the associate and its carrying value and recognises the amount in the "share of profit of an associate" in the income statement. Upon loss of significant influence over the associate, the Company measures and recognises any retaining investment at its fair value. Any difference between the carrying amount of the associate upon loss of significant influence and the fair value of the retaining investment and proceeds from disposal is recognised in profit or loss.

 

d) Cash on deposit

Cash on deposits comprise bank deposits with an original maturity of three months or more.

 

e) Cash and cash equivalents

Cash and cash equivalents comprise bank balances and cash held by the Company including short-term bank deposits with an original maturity of three months or less. Cash also includes amounts held in interest bearing overnight accounts.

 

f) Other receivables and payables

Other receivables do not carry any interest and are short-term in nature and are accordingly stated at their nominal value as reduced by appropriate allowances for estimated irrecoverable amounts. Other payables are not interest-bearing and are stated at their nominal value.

 

g) Financial liabilities and equity

Financial liabilities and equity are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities. Financial liabilities and equity are recorded at the amount of proceeds received, net of issue costs.

 

h) Zero Dividend Preference ("ZDP") shares

In accordance with International Accounting Standard 32 - Financial Instruments: Presentation, ZDP shares have been disclosed as a financial liability as the shares are redeemable at a fixed date and holders are entitled to a fixed return. ZDP shares are recorded at amortised cost using the effective interest rate method.

 

Income

Interest income for all interest bearing financial instruments are included on an accruals basis using the effective interest method. Dividend income is recognised when the Company's right to receive payment is established. When there is reasonable doubt that income due to be received will actually be received, such income is not accrued until it is clear that its receipt is probable. Where following an accrual of income, receipt becomes doubtful, the accrual is either fully or partly written off until the reasonable doubt is removed.

 

Expenses

Investment Adviser's basic fees are allocated to revenue. The Company will also provide for a Capital Gains Incentive fee based on net unrealised investments gains.

 

Expenses which are deemed to be incurred wholly in connection with the maintenance or enhancement of the value of the investments are charged to realised capital reserve. All other expenses are accounted for on an accruals basis and are presented as revenue items.

 

Finance costs

Finance costs are interest expenses in respect of the ZDP shares and are recognised in the Statement of Comprehensive Income using the effective interest method.

 

Escrow accounts

Where investments are disposed of, the consideration given may include contractual terms requiring that a percentage of the consideration is held in an escrow account pending resolution of any indemnifiable claims that may arise and as such the value of these escrow amounts is not immediately known. The Company records gains realised on investments held in escrow in the Statement of Comprehensive Income following confirmation that any such indemnifiable claims have been resolved and none are expected in the future.

 

3. Segment Information

The Investment Adviser is responsible for allocating resources available to the Company in accordance with the overall business strategies as set out in the Investment Guidelines of the Company. The Company has been organised into the following segments:

 

·; Portfolio of bank debt

·; Portfolio of mezzanine investments

·; Portfolio of US micro cap investments

·; Portfolio of European micro cap investments

·; Portfolio of legacy investments

·; Portfolio of listed investments.

 

The investment objective of each segment is to achieve consistent medium-term returns from the investments in each segment while safeguarding capital by investing in diversified portfolios.

 

Investment in treasury gilts/notes are not considered part of any individual segment and have therefore been excluded from this segmental analysis.

 

There have been no changes in reportable segments during the course of the year. The segment information provided is also presented to the Board of the Company.

 

Segmental operating profit/(loss)

For the year ended 29 February 2012

Bank

Debt

US$'000

Mezzanine

Portfolio

US$'000

Micro Cap

US

US$'000

Micro Cap

European

US$'000

Legacy

Portfolio

US$'000

Listed

Investments

US$'000

 

Total

US$'000

Interest revenue

2,483

5,387

24,785

1,377

4,301

-

38,333

Dividend revenue

-

-

-

-

-

4,577

4,577

Other revenue

249

-

-

-

-

-

249

Net gain/(loss) on investments at fair value through profit or loss

 

4,246

 

3,080

 

2,130

 

(576)

 

3,098

 

(5,529)

 

6,449

Share of associate's net income

-

-

-

20,797

-

-

20,797

Impairments on loans and receivables

 

-

 

142

 

-

 

-

 

-

 

-

 

142

Investment Adviser's base fee

(593)

(695)

(3,949)

(1,424)

(921)

(977)

(8,559)

Investment Adviser's capital incentive fee*

 

-

 

(63)

 

(3,267)

 

(486)

 

-

 

(1,541)

 

(5,357)

Investment Adviser's income incentive fee**

 

(104)

 

(255)

 

(3,922)

 

(68)

 

-

 

(61)

 

(4,410)

Total segmental operating profit

6,281

7,596

15,777

19,620

6,478

(3,531)

52,221

 

 

 

For the year ended 28 February 2011

Bank

Debt

US$'000

Mezzanine

Portfolio

US$'000

Micro Cap

US

US$'000

Micro Cap

European

US$'000

Legacy

Portfolio

US$'000

Listed

Investments

US$'000

 

Total

US$'000

Interest revenue

2,907

8,832

19,693

999

3,005

-

35,436

Dividend revenue

-

-

-

-

-

4,093

4,093

Other revenue

77

1,198

-

-

138

-

1,413

Net gain on investments at fair value through profit or loss

 

17,319

 

(66)

 

42,184

 

2,029

 

21,350

 

35,374

 

118,190

Net impairments on loans and receivables

 

-

 

(2,019)

 

-

 

-

 

-

 

-

 

(2,019)

Investment Adviser's base fee

(600)

(851)

(3,905)

(720)

(748)

(1,843)

(8,667)

Investment Adviser's capital incentive fee*

 

1,518

 

2,255

 

(5,578)

 

-

 

-

 

-

 

(1,805)

Total segmental operating profit

21,221

9,349

52,394

2,308

23,745

37,624

146,641

 

\* The capital incentive fee is allocated across segments where a realised or unrealised gain or loss has occurred. Segments with realised or unrealised losses are allocated a credit pro rata to the size of the loss and segments with realised or unrealised gains are allocated a charge pro rata to the size of the gain.

 

** The income incentive fee is allocated across segments in the ratio of the investment income earned during the quarter in which the fee became payable

 

Segmental assets

At 29 February 2012

Bank

Debt

US$'000

Mezzanine

Portfolio

US$'000

Micro Cap

US

US$'000

Micro Cap

European

US$'000

Legacy

Portfolio

US$'000

Listed

Investments

US$'000

 

Total

US$'000

Investments at fair value through profit or loss

 

32,512

 

5,658

 

181,655

 

15,179

 

25,312

 

88,639

 

348,955

Investments classified as loans and receivables

 

-

 

23,974

 

-

 

-

 

-

 

-

 

23,974

Investment in an associate

-

-

-

69,950

-

-

69,950

Total segmental assets

32,512

29,632

181,655

85,129

25,312

88,639

442,879

 

Segmental assets

At 28 February 2011

Bank

Debt

US$'000

Mezzanine

Portfolio

US$'000

Micro Cap

US

US$'000

Micro Cap

European

US$'000

Legacy

Portfolio

US$'000

Listed

Investments

US$'000

 

Total

US$'000

Investments at fair value through profit or loss

 

34,121

 

2,547

 

230,983

 

32,517

 

42,620

 

105,016

 

447,804

Investments classified as loans and receivables

 

-

 

45,952

 

-

 

-

 

-

 

-

 

45,952

Total segmental assets

34,121

48,499

230,983

32,517

42,620

105,016

493,756

 

Certain income and expenditure is not considered part of the performance of an individual segment. This includes net foreign exchange gains, interest on cash, finance costs, management fees, custodian and administration fees, Directors' fees and other general expenses.

 

3. Segment Information

 

The following table provides a reconciliation between net reportable segment income and operating profits.

 

Year ended

Year ended

29/02/2012

28/02/2011

US$'000

US$'000

Net reportable segment profit

52,221

146,641

Net gains on treasury gilts/notes

605

2,553

Realised gains on investments held in escrow accounts

2,093

2,553

Net foreign exchange gains/(losses)

1,694

1,438

Interest on treasury notes

399

286

Interest on cash

460

(5,008)

Fees payable to investment adviser based on non segmental assets

 

(1,688)

 

343

Expenses not attributable to segments

(2,786)

(2,382)

Operating profit

52,998

143,871

 

Other receivables and prepayments are not considered to be part of individual segment assets. Certain liabilities are not considered to be part of the net assets of an individual segment. These include custodian and administration fees payable, Directors' fees payable and other payables and accrued expenses.

 

The following table provides a reconciliation between net total segment assets and liabilities and total assets and liabilities.

 

29/02/2012

28/02/2011

US$'000

US$'000

Total segmental assets

442,879

493,756

Treasury gilts

33,465

-

Floating rate notes

32,129

-

Cash held on deposit

7,968

-

Cash and cash equivalents

194,513

172,267

Other receivables and prepayments

451

464

Total assets

711,405

666,487

Total segmental liabilities

-

-

Other payables and accrued expenses

(95,943)

(85,699)

Total liabilities

(95,943)

(85,699)

 

4. Critical Accounting Judgements and Key Sources of Estimation Uncertainty

The following are the key assumptions and other key sources of estimation uncertainty at the end of the reporting period, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year:

 

Fair value of investments at fair value through profit or loss ("FVTPL")

Certain investments are classified as FVTPL, and valued accordingly, as disclosed in Note 2 and the valuation policy as stated in Note 2. The key source of estimation uncertainty is on the valuation of unquoted equities and equity-related securities.

In reaching the valuation of the unquoted equities and equity related securities the critical judgements and key sources of uncertainty are the selection of multiples for comparable companies and the discount factors used in valuation models.

 

Loans and receivables

Certain investments are classified as Loans and Receivables, and valued accordingly, as disclosed in Note 2 and the valuation policy as stated in Note 2. The key estimation is the impairment review and the key assumptions as disclosed in Note 2.

 

5. Net gain on investments at fair value through profit or loss

 

Year ended

Year ended

29/02/2012

28/02/2011

US$'000

US$'000

Movement in unrealised gains on investments

(11,284)

90,189

Proceeds from investments disposed/realised

197,663

216,757

Cost of investments disposed/realised

(141,696)

(181,360)

Unrealised gains in prior year now realised

(37,629)

(5,958)

Total net realised gains in year

18,338

29,439

Net gain on investments in year

7,054

119,628

 

6. Net (impairments)/write back of impairments on loans and receivables

 

Year ended

Year ended

29/02/2012

28/02/2011

US$'000

US$'000

Net impairments on loans and receivables

(174)

(3,369)

 

Proceeds from investments disposed/realised

29,118

35,052

Cost of investments disposed/realised

(28,227)

(33,702)

Unrealised gains in prior year now realised

(575)

-

Net realised gain

316

1,350

Net (impairments)/write back of impairments on loans and receivables

 

142

 

(2,019)

 

7. Investment income

 

Year ended

Year ended

29/02/2012

28/02/2011

US$'000

US$'000

Income from investments classified as FVTPL

38,202

32,421

Income from investments classified as loans and receivables

5,356

 

8,807

 

43,558

41,228

 

Income for the year ended 29 February 2012

 

Preference Dividend Loan note Other Other

Dividends

US$ '000

PIK

US$ '000

Cash

US$ '000

PIK

US$ '000

Cash

US$ '000

Interest

 US$ '000

Income

US$ '000

Total

US$'000

1st and 2nd Lien bank debt

-

-

-

-

-

2,483

249

2,732

Mezzanine portfolio

-

31

-

360

4,996

-

-

5,387

US Micro Cap portfolio

-

16,595

-

3,540

4,650

-

-

24,785

European Micro Cap portfolio

 

-

 

-

 

-

 

-

 

1,377

 

-

 

-

 

1,377

Legacy portfolio

-

73

-

2,892

1,336

-

-

4,301

Listed investments

4,577

-

-

-

-

-

-

4,577

Treasury and floating rate notes

 

-

 

-

 

-

 

-

 

-

 

399

 

-

 

399

4,577

16,699

-

6,792

12,359

2,882

249

43,558

 

7. Investment income

 

Income for the year ended 28 February 2011

 

Preference Dividend Loan note Other Other

Dividends

US$ '000

PIK

US$ '000

 

Cash

US$ '000

PIK

US$ '000

Cash

US$ '000

Interest

 US$ '000

Income

US$ '000

Total

US$'000

1st and 2nd Lien bank debt

-

-

 -

-

 -

2,907

77

2,984

Mezzanine portfolio

-

25

-

433

8,374

-

1,198

10,030

Micro Cap portfolio

-

11,757

365

3,485

5,085

-

-

20,692

Legacy portfolio

-

73

-

2,798

134

-

138

3,143

Listed investments

4,093

-

-

-

-

-

-

4,093

Treasury notes

-

-

-

-

-

286

-

286

4,093

11,855

365

6,716

13,593

3,193

1,413

41,228

 

Interest on investments is shown net of a US$7,704,000 (year ended 28 February 2011: US$8,247,000) write down calculated in accordance with the Company's accounting and valuation policy.

 

8. Finance costs

 

Year ended

Year ended

29/02/2012

28/02/2011

US$'000

US$'000

Zero Dividend Preference shares

6,581

5,938

6,581

5,938

 

Finance costs arising are allocated to the Statement of Comprehensive Income using the effective interest rate method. The rights and entitlements of the ZDP shares, which are accounted for at amortised cost are described in Note 16.

 

9. Expenses

 

Year ended

Year ended

29/02/2012

28/02/2011

US$'000

US$'000

Investment Adviser's base fee

10,247

8,667

Investment Adviser's capital incentive fee

5,357

2,093

Investment Adviser's income incentive fee

4,410

-

20,014

10,760

Administrative expenses:

Legal and professional fees

1,308

556

Other expenses

504

554

Directors' remuneration

380

380

Accounting, secretarial and administration fees

400

400

Auditors' remuneration

164

194

Custodian fees

30

10

2,786

2,094

Total expenses

22,800

12,854

 

Directors fees

The Chairman is entitled to a fee of US$140,000 per annum. Each of the other Directors are entitled to a fee of US$60,000 per annum. For the year ended 29 February 2012 total Directors' fees included in the Statement of Comprehensive Income were US$380,000 (year ended 28 February 2011: US$380,000), of this amount US$63,000 was outstanding at the year end (28 February 2011: US$63,000) and included within Other Payables.

 

Investment advisory and performance fees

The Company entered into an investment advisory and management agreement with Jordan/Zalaznick

 

9. Expenses (continued)

 

Advisers, Inc (the "Investment Adviser") in May 2008 which was then amended and restated on 20 May 2009 and again on 23 December 2010 (the "Advisory Agreement").

 

Pursuant to the Advisory Agreement, the Investment Adviser is entitled to a base management fee and to an incentive fee. The base management fee is an amount equal to 1.5 per cent. per annum of the average total assets under management of the Company less those assets identified by the Company as being excluded from the base management fee. The base management fee is payable quarterly in arrears; the agreement provides that payments in advance on account of the base management fee will be made.

 

The incentive fee has two parts. The first part is calculated by reference to the net investment income of the Company ("Income Incentive Fee") and is payable quarterly in arrears provided that the net investment income for the quarter exceeds 2 per cent of the average of the net asset value of the Company for that quarter (the "hurdle") (8 per cent. annualised). The fee is an amount equal to (a) 100 per cent of that proportion of the net investment income for the quarter as exceeds the hurdle, up to an amount equal to a hurdle of 2.5%, and (b) 20 per cent. of the net investment income of the Company above a hurdle of 2.5% in any quarter. Change in the valuation of income related (PIK) investments are also classed as an increase or decrease to investment income. Investments categorised as legacy investments and other assets identified by the Company as being excluded are excluded from the calculation of the fee. A true-up calculation is also payable at the end of each financial year to determine if further fees are payable to the Investment Adviser or if any amounts are recoverable from future income incentive fees.

 

For the year ended 29 February an amount of US$4,409,700 was paid on the basis that the net investment income of the Company as determined in the Advisory Agreement exceeded the third quarter hurdle rate of 2% (8% per annum). This is further discussed in Note 29.

 

The second part of the incentive fee is calculated by reference to the net realised capital gains ("Capital Incentive Fee") of the Company and is equal to: (a) 20 per cent. of (x) the realised capital gains of the Company for each financial year less (y) all realised capital losses of the Company for the year less (b) the aggregate of all previous capital gains incentive fees paid by the Company to the Investment Adviser. The capital gains incentive is payable in arrears within 90 days of the fiscal year end. Investments categorised as legacy investments and those assets of the Euro Microcap Fund 2010, LP are excluded from the calculation of the fee.

 

For the year ended 29 February 2012 total Investment advisory and management expenses, based on the average total assets of the Company, were included in the Statement of Comprehensive Income of US$10,247,000 (28 February 2011: US$8,667,000) of this amount US$1,105,000 (28 February 2011: US$713,000) was outstanding at the period end and is included within Other Payables.

 

The Company provides for a capital gains incentive fee based on cumulative net realised and unrealised investments gains. At 29 February 2012 the provision for the capital gains incentive fee was US$5,357,000 (28 February 2011: US$2,093,000).

 

29/02/2012

28/02/2011

Provision for capital incentive fee

US$'000

US$'000

Provision based on realised gains and payable within 90 days of the fiscal year

 

5,357

 

2,093

Provision based on unrealised gains at the fiscal year end

-

-

5,357

2,093

 

The value of investments included in the calculation of the capital incentive fee based on unrealised gains excludes accrued income and PIK investments.

 

The Advisory agreement may be terminated by the Company or the Investment Advisor upon not less than two and one-half years' (i.e. 913 days') prior notice (or such lesser period as may be agreed by the Company and Investment Adviser).

 

9. Expenses

 

Administration fees

Butterfield Fund Services (Guernsey) Limited was appointed on 12 May 2008 under an Administration, Secretarial and Registrar Agreement. Butterfield Fund Services and Fulcrum Group merged during September 2008 forming Butterfield Fulcrum Group (Guernsey) Limited (the "Administrator").

 

The Administrator is entitled to a quarterly fee of US$100,000 payable monthly (quarterly pre 1 October 2010) in arrears. Fees payable are subject to an annual fee review. For the year ended 29 February 2012 total expenses payable to the Administrator of US$400,000.

 

(28 February 2011: US$400,000) were included in the Statement of Comprehensive Income, of this amount US$67,000 (28 February 2011: US$33,000) was outstanding at the year end and is included within Other Payables.

 

Custodian fees

HSBC Bank (USA) N.A (the "Custodian") was appointed on 12 May 2008 under a custodian agreement. The Custodian is entitled to receive an annual fee of US$2,000 and a transaction fee of US$50 per transaction. For the year ended 29 February 2012 total expenses were included in the Statement of Comprehensive Income of US$30,000 (28 February 2011: US$10,000) of which US$nil (28 February 2011: US$1,000) was outstanding at the year end and is included within Other Payables.

 

Auditors remuneration

All of the auditors remuneration relates to the annual audit and half year review report. During the year ended 29 February 2012 professional fees of US$65,000 were paid in the year to Ernst & Young for taxation services.

 

10. Taxation

For both 2012 and 2011 the Company applied for and was granted exempt status for Guernsey tax purposes under the terms of The Income Tax (Zero 10) (Guernsey) Law, 2007.

 

For the year ended 29 February 2012 the Company suffered withholding tax of US$1,373,000 (28 February 2011: US$690,000) on dividend income from listed investments.

 

11. Investments

 

Categories of financial instruments

 

Listed

 

Unlisted

Carrying Value

29/02/2012

29/02/2012

29/02/2012

US$ '000

US$ '000

US$ '000

Fair value through profit or loss (FVTPL)

154,233

260,316

414,549

Loans and receivables

-

23,974

23,974

Investment in an associate

-

69,950

69,950

154,233

354,240

508,473

 

 

Listed

 

Unlisted

Carrying Value

28/02/2011

28/02/2011

28/02/2011

US$ '000

US$ '000

US$ '000

Fair value through profit or loss (FVTPL)

105,016

342,788

447,804

Loans and receivables

-

45,952

45,952

105,016

388,740

493,756

 

11. Investments

 

Listed

Unlisted

Total

29/02/2012

29/02/2012

29/02/2012

US$ '000

US$ '000

US$ '000

Book cost at 1 March 2011

75,017

394,118

469,135

Purchases in year

64,847

73,729

138,576

Capital calls during year

-

49,153

49,153

Payment in kind ("PIK")

-

25,995

25,995

Proceeds from investments disposed/realised

(10,850)

(215,204)

(226,054)

Realised gains on disposal

3,563

53,295

56,858

 

 

Book cost at 29 February 2012

132,577

381,086

513,663

Unrealised gains(losses) at 29 February 2012

21,514

(33,310)

(11,796)

Accrued interest at 29 February 2012

142

6,464

6,606

Carrying value at 29 February 2012

154,233

354,240

508,473

 

 

The above book cost is the cost to JZCP equating to the transfer value as at 1 July 2008 upon the liquidation of JZEP and adjusted for subsequent transactions.

 

The cost of PIK investments is deemed to be the interest recognised in the Statement of Comprehensive Income that has not been received in cash but settled by the issue of further securities.

 

Investment in associate

At 29 February 2012 the Company had one associate carrying on business which affects the profits and assets of the Company. The Company's associate consists solely of limited partnership interest directly held in the Partnership, which applies accounting policies that are consistent with the Company's.

 

Entity

Principal activity

% Interest

EuroMicrocap Fund 2010, LP

Acquiror of Europe-based microcap companies

75%

 

The Company's share of the aggregated financial information of the equity accounted associate is set out below. The amounts for the year ended 29 February 2012 include the share of results and net assets in the associate from the date of establishment to 29 February 2012.

 

29/02/2012

28/02/2011

US$'000

US$'000

Share of result in associate

20,797

-

Non current assets

68,795

-

Current liabilities

1,155

-

69,950

-

 

12. Cash held on deposit

 

29/02/2012

28/02/2011

US$'000

US$'000

Cash held on deposit

7,968

-

7,968

-

 

Cash held on deposit includes bank deposits with an original maturity of three months or more. The carrying value of these assets approximates to their fair value.

 

13. Cash and cash equivalents

 

29/02/2012

28/02/2011

US$'000

US$'000

Cash at bank

194,513

172,267

194,513

172,267

 

Cash and cash equivalents comprise bank balances and cash held by the Company including short-term bank deposits with an original maturity of three months or less. The carrying value of these assets approximates to their fair value.

 

14. Other receivables

 

29/02/2012

28/02/2011

US$'000

US$'000

Accrued dividend income on listed investments

405

405

Other prepayments

44

31

Bank and deposit interest

2

28

451

464

 

15. Other payables

 

29/02/2012

28/02/2011

US$'000

US$'000

Investment Adviser's fees

6,462

2,806

Payable on unsettled trades

790

-

Provision for tax on not withheld at source on dividends received

 

679

 

-

Legal fees

300

255

Other expenses

222

133

Auditors' remuneration

79

68

Directors' remuneration

63

63

Fees due to administrator

67

33

8,662

3,358

 

16. Zero Dividend Preference ("ZDP") shares

Authorised Capital

Unlimited number of ZDP shares of no par value.

29/02/2012

28/02/2011

US$'000

US$'000

ZDP shares redeemed 22 June 2009

Amortised cost at 1 March

82,341

71,399

Finance costs allocated to statement of comprehensive income

 

6,581

 

5,938

Unrealised currency gain on translation during the year

(1,641)

5,004

Amortised cost at year end

87,281

82,341

Total number of ZDP shares in issue

20,707,141

20,707,141

Price per ZDP share US$

US$ 4.2254

US$ 3.9892

Price per ZDP share GBP

GBP 2.6513

GBP 2.4549

 

16. Zero Dividend Preference ("ZDP") shares

 

ZDP shares were issued on 22 June 2009 at a price of 215.80 pence and are designed to provide a pre-determined final capital entitlement of 369.84 pence on 22 June 2016 which ranks behind the Company's creditors but in priority to the capital entitlements of the Ordinary shares. The ZDP shares carry no entitlement to income and the whole of their return will therefore take the form of capital. The capital appreciation of approximately 8% per annum is calculated monthly. In certain circumstances, ZDP shares carry the right to vote at general meetings of the Company as detailed in the Company's Memorandum of Articles and Association. Issue costs are deducted from the cost of the liability and allocated to the statement of comprehensive income over the life of the ZDP shares.

 

17. Share Capital

 

Authorised Capital

Unlimited number of ordinary shares of no par value.

 

Ordinary shares - Issued Capital

29/02/2012

28/02/2011

Number of shares

Number of shares

Balance at 1 March

42,913,132

42,913,132

Issued during year

1,300,000

-

Share consolidation 1 for 5

(6,893,895)

-

Total ordinary shares in issue

37,319,237

42,913,132

 

Limited Voting Ordinary shares - Issued Capital

29/02/2012

28/02/2011

Number of shares

Number of shares

Balance at 1 March

22,105,478

22,105,478

Converted to Ordinary shares

(1,300,000)

-

Converted from Ordinary shares

6,893,895

-

Total limited voting ordinary shares in issue

27,699,373

22,105,478

Total shares in issue

65,018,610

65,018,610

 

Limited Voting Ordinary shares ("LVO") were issued so that certain of the Company's existing Shareholders and certain US new investors could participate in the Ordinary Share Issue without causing the Company to be treated as a US domestic company for the purposes of US securities laws and/or a CFC for US tax purposes. LVO shares are identical to, and rank pari passu in all respects with, the New Ordinary shares except that the LVO shares will only carry a limited entitlement to vote in respect of the appointment or removal of Directors and will not carry any entitlement to vote in respect of certain other matters. The LVO shares are not listed and are not admitted to trade on or through the facilities of the London Stock Exchange.

 

During the year ended 29 February 2012, 1,300,000 Ordinary shares were admitted to the Official List of the UK Financial Services Authority and to dealings on the London Stock Exchange's market for listed securities following the conversion of LVO shares.

 

On 25 August 2011, a total of 6,893,895 Ordinary shares were converted into Limited Voting Ordinary shares following the request of a number of US shareholders.

 

The Ordinary shares and LVO shares carry a right to receive the profits of the Company available for distribution by dividend and resolved to be distributed by way of dividend to be made at such time as determined by the Directors.

 

In addition to receiving the income distributed, the Ordinary shares and LVO shares are entitled to the net assets of the Company on a winding up, after all liabilities have been settled and the entitlement of the ZDP shares have been met. In addition, holders of Ordinary shares and LVO shares will be entitled on a winding up to receive any accumulated but unpaid Revenue reserves of the Company, subject to all creditors having been paid out in full but in priority to the entitlements of the ZDP shares.

 

17. Share Capital

 

Any distribution of Revenue reserves on a winding up is currently expected to be made by way of a final special dividend prior to the Company's eventual liquidation.

 

Holders of Ordinary shares shall have the rights to receive notice of, to attend and to vote at all general meeting of the Company.

 

Further issue of shares

Under the Articles, the Directors have the power to issue new shares on a non pre-emptive basis. The Directors have resolved, however, that new shares will not be issued at a discount to the prevailing Net Asset Value per Ordinary share other than where shareholders are permitted to participate in the issue pro rata to their existing holding in the Company and, therefore, will not be disadvantageous to existing shareholders. Future issues of shares will be carried out in accordance with the Listing Rules.

 

The Directors will consider issuing new shares at not less than the prevailing Net Asset Value per Ordinary share where there is a significant demand for further shares.

 

Purchase of own shares by the Company

It is the intention of the Directors to seek authority from shareholders on a regular basis to allow the Company to repurchase shares in the market to prevent the emergence of a significant discount on the Company's market price to the Company's Net Asset Value.

 

18. Capital management

 

The Company's capital is represented by the Ordinary shares, LVO shares and ZDP shares.

 

As a result of the ability to issue, repurchase and resell shares, the capital of the Company can vary. The Company is not subject to externally imposed capital requirements and has no restrictions on the issue, repurchase or resale of its shares.

 

The Company's objectives for managing capital are:

 

• To invest the capital in investments meeting the description, risk exposure and expected return indicated in its prospectus.

• To achieve consistent returns while safeguarding capital by investing in a diversified portfolio.

• To maintain sufficient liquidity to meet the expenses of the Company, and to meet redemption requests as they arise.

• To maintain sufficient size to make the operation of the Company cost-efficient.

 

The Company continues to keep under review opportunities to buy back Ordinary or ZDP shares.

 

The Company monitors capital by analysing the NAV per share over time and tracking the discount to the Company's share price. It also monitors the performance of the existing investments to identify opportunities for exiting at a reasonable return to the shareholders.

 

19. Reserves

 

Capital raised on formation of the Company

The Royal Court of Guernsey granted that on the admission of the Company's shares to the official list and to trading on the London Stock Exchange's market, the amount credited to the share premium account of the Company immediately following the admission of such shares be cancelled and any surplus thereby created accrue to the Company's distributable reserves to be used for all purposes permitted by the Companies Law, including the purchase of shares and the payment of dividends.

 

Capital raised on issue of new shares

Subsequent amounts raised by the issue of new shares, net of issue costs, are credited to a share capital account.

 

Distributable reserves

Subject to satisfaction of the solvency test, all of the Company's capital and reserves are distributable in accordance with the Companies (Guernsey) Law, 2008.

 

19. Reserves

 

Summary of reserves attributable to Ordinary shareholders

29/02/2012

28/02/2011

US$'000

US$'000

Distributable reserve

353,528

353,528

Share capital account

149,269

149,269

Capital reserve

41,775

21,933

Revenue reserve

70,890

56,058

615,462

580,788

 

 

Distributable reserve

29/02/2012

28/02/2011

US$'000

US$'000

US$ '000

US$ '000

At 1 March 2011

353,528

353,517

Increase in provisions/receivables relating to JZ Equity Partners Plc

 

-

 

11

At 29 February 2012

353,528

353,528

 

Share capital account

29/02/2012

28/02/2011

US$ '000

US$ '000

At 1 March 2011

149,269

149,269

At 29 February 2012

149,269

149,269

 

Capital reserve

All surpluses arising from the realisation or revaluation of investments and all other capital profits and accretions of capital shall be credited to the Capital reserve. Any loss arising from the realisation or revaluation of investments or any expense, loss or liability classified as capital in nature may be debited to the Capital reserve.

 

Capital reserve

Realised

Unrealised

Total

29/02/2012

29/02/2012

29/02/2012

US$ '000

US$ '000

US$ '000

At 1 March 2011

14,525

7,408

21,933

Net gains/(losses) on investments

56,858

(28,865)

27,993

Unrealised net foreign currency exchange gains

-

1,706

1,706

Realised gains on investments held in escrow accounts

 

2,093

 

-

 

2,093

Realised net foreign currency exchange losses

(12)

-

(12)

Expenses charged to capital

(5,357)

(6,581)

(5,357)

Finance costs in respect of Zero Dividend Preference

 

-

 

-

 

(6,581)

At 29 February 2012

68,107

(26,332)

41,775

 

19. Reserves

 

Capital reserve

Realised

Unrealised

Total

28/02/2011

28/02/2011

28/02/2011

US$ '000

US$ '000

US$ '000

At 1 March 2010

(16,729)

(68,461)

(85,190)

Net gains on investments

30,789

86,820

117,609

Unrealised net foreign currency exchange losses

-

(5,013)

(5,013)

Realised gains on investments held in escrow accounts

 

2,553

 

-

 

2,553

Realised net foreign currency exchange losses

5

-

5

Expenses charged to capital

(2,093)

-

(2,093)

Finance costs in respect of Zero Dividend Preference

 

-

 

(5,938)

 

(5,938)

At 28 February 2011

14,525

7,408

21,933

 

Revenue reserve

29/02/2012

28/02/2011

US$ '000

US$ '000

At 1 March 2011

56,058

39,917

Profit for the year attributable to revenue

25,202

30,120

Dividend paid

(10,370)

 (13,979)

At 29 February 2012

70,890

56,058

 

20. Financial Instruments

 

Categories of financial instruments

 

Carrying Value

Carrying Value

29/02/2012

28/02/2011

US$ '000

US$ '000

Financial assets

Fair value through profit or loss (FVTPL)

414,549

447,804

Loans and receivables

23,974

45,952

Investment in associate

69,950

-

Other receivables

451

464

Cash held on deposit (maturity date > 3 months)

7,968

-

Cash and cash equivalents

194,513

172,267

Total assets

711,405

666,487

Financial liabilities

Valued at amortised cost

- Zero Dividend Preference ("ZDP") shares

(87,281)

(82,341)

Trade payables

(8,662)

(3,358)

Total liabilities

(95,943)

(85,699)

 

Loans and receivables presented above represent mezzanine loans.

 

Financial liabilities measured at amortised cost presented above represent ZDP shares, balances due to brokers and trade payables as detailed in the statement of financial position.

 

21. Financial risk and management objectives and policies

Introduction

The Company's objective in managing risk is the creation and protection of shareholder value. Risk is inherent in the Company's activities, but it is managed through a process of ongoing identification, measurement and monitoring, subject to risk limits and other controls. The process of risk management is critical to the Company's continuing profitability. The Company is exposed to market risk (which includes currency risk, interest rate risk and price risk), credit risk and liquidity risk arising from the financial instruments it holds.

 

21. Financial risk and management objectives and policies

 

Risk management structure

The Company's Investment Adviser is responsible for identifying and controlling risks. The Directors supervise the Investment Adviser and are ultimately responsible for the overall risk management approach within the Company.

 

Risk mitigation

The Company's prospectus sets out its overall business strategies, its tolerance for risk and its general risk management philosophy. The Company may use derivatives and other instruments for trading purposes and in connection with its risk management activities, but has not done so during the year.

 

Market risk

Market risk is defined as "the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in variables such as equity price, interest rate and foreign currency rate".

 

Market price risk

The Company's investments are subject to normal market fluctuations and there can be no assurance that no depreciation in the value of those investments will occur. There can be no guarantee that any realisation of an investment will be on a basis which necessarily reflects the Company's valuation of that investment for the purposes of calculating the Net Asset Value of the shares.

 

Changes in industry conditions, competition, political and diplomatic events, tax, environmental and other laws and other factors, whether affecting the United States alone or other countries and regions more widely, can substantially and either adversely or favourably affect the value of the securities in which the Company invests and, therefore, the Company's performance and prospects.

 

The Company's market price risk is managed through diversification of the investment portfolio across various sectors. The Investment Adviser considers each investment purchase to ensure that an acquisition will enable the Company to continue to have an appropriate spread of market risk and that an appropriate risk/reward profile is maintained.

 

Equity price risk (listed investments)

Equity price risk is the risk of unfavourable changes in the fair values of equity investments as the result of changes in the value of individual shares. The equity price risk exposure arises from the Company's investments in equity securities. The Company has three equity investments valued at US$88,639,000 (28 February 2011: US$105,016,000) which are listed on the NASDAQ, and NYSE.

 

The Company does not generally invest in liquid equity investments and the current portfolio of the listed equity investments result from the successful flotation of unlisted investments.

 

Management's best estimate of the effect on the net assets attributable to shareholders and on the profit for the year due to a reasonably possible change in equity indices, assuming changes in value are fully correlated to changes in the index, with all other variables held constant is indicated in the table below. In practice, the actual trading results may differ from the sensitivity analysis below and the difference could be material. An equivalent decrease in each of the indices shown below would have resulted in an equivalent, but opposite, impact.

 

Sensitivity analysis for change in value of listed equity resulting from increase/decrease in relevant indicies:

 

 

Markets

 

 

Change in

indices

Carrying value of listed equities

29/02/2012

US$'000

Effect on the net assets attributable to shareholders

29/02/2012

US$'000

NYSE

10%

39,276

3,928

NASDAQ

10%

49,363

4,936

88,639

8,864

 

21. Financial risk and management objectives and policies

 

 

 

Markets

 

 

Change in

indices

Carrying value of listed equities

28/02/2011

US$'000

Effect on the net assets attributable to shareholders

28/02/2011

US$'000

NYSE

10%

49,335

4,933

NASDAQ

10%

55,681

5,568

105,016

10,501

 

The table below analyses the Company's concentration of equity price risk by industrial distribution:

 

Percentage of equity securities

29/02/2012

28/02/2011

Property and Casualty Insurance

55.7%

53.0%

Education and Training Services

1.0%

1.2%

Rental and Leasing Services

43.3%

45.8%

100.0%

100.0%

 

The Company has certain financial instruments (common stock private investments) that are recorded at fair value using valuation techniques such as an Earnings multiple model derived either from acquisition/purchase information or observable market data from comparable companies. In some cases an adjustment is made to the acquisition/purchase multiple to reflect the underlying growth of the investment. These are adjusted to reflect counter party credit risk and limitations in the model.

 

Equity price risk (unlisted investments)

For the financial instruments whose fair value is estimated using valuation techniques with no market observable inputs, the net unrealised amount recorded in the statement of comprehensive income in the year due to changes in the inputs amounts to losses of US$6,224,000. (28 February 2011: gains of US$20,876,000).

 

The table below analyses the Company's concentration of common stock private investments by industrial distribution and the effect on the net assets attributable to shareholders and on the increase/(decrease) in profit for the year due to a reasonably possible change in the value of EBITDA. In practice, the actual trading results may differ from the sensitivity analysis below and the difference could be material.

 

 

 

 

 

Industry

 

 

 

Carrying Value

Percentage of total common stock of private investments

 

 

 

Change in EBITDA

 

Effect on the net assets attributable to shareholders

29/02/2012

29/02/2012

29/02/2012

US$ '000

US$ '000

Testing Laboratory

5,043

37%

10% /-10%

715 / (715)

Roofing Supplies

3,780

28%

10% /-10%

690 / (690)

Industrial Investment Firms

1,809

13%

10% /-10%

N/A

Pet Supplies

1,636

12%

10% /-10%

N/A

Specialized Equipment

 Manufacturers

 

443

 

3%

 

10% /-10%

 

N/A

Personal Care Products

328

3%

10% /-10%

N/A

Strategic Workforce Solutions

300

2%

10% /-10%

N/A

Other

229

2%

10% /-10%

220 / 0

Sensors & Instrumentation

37

0%

10% /-10%

N/A

13,605

100%

1,625 / (1,405)

 

 

21. Financial risk and management objectives and policies

 

 

 

 

 

Industry

 

 

 

Carrying Value

Percentage of total common stock of private investments

 

 

 

Change in EBITDA

 

Effect on the net assets attributable to shareholders

28/02/2011

28/02/2011

28/02/2011

US$ '000

US$ '000

Business Services

9,500

29%

10% /-10%

3,300 / (3,300)

Specialised Equipment

 Manufacturers

 

9,400

 

29%

 

10% /-10%

 

1,500 / (1,500)

Chemical

9,400

29%

10% /-10%

1,000 / (1,000)

Pet Supplies

1,636

5%

10% /-10%

N/A

Roofing Supplies

700

2%

10% /-10%

460 / (460)

Industrial Investment Firms

1,101

3%

10% /-10%

N/A

Personal Care Products

400

1%

10% /-10%

N/A

Strategic Workforce Solutions

300

1%

10% /-10%

N/A

Other

359

1%

10% /-10%

N/A

32,796

100%

6,260 / (6,260)

 

Interest rate risk

Interest rate risk arises from the possibility that changes in interest rates will affect future cash flows or the fair values of financial instruments. It has not been the Company's policy to use derivative instruments to mitigate interest rate risk, as the Investment Adviser believes that the effectiveness of such instruments does not justify the costs involved.

 

The table below summarises the Company's exposure to interest rate risks:

 

Fixed rate

 

Floating rate

Non interest

bearing

 

Total

29/02/2012

29/02/2012

29/02/2012

29/02/2012

US$ '000

US$ '000

US$ '000

US$ '000

Investments at fair value through profit or loss

 

247,664

 

64,641

 

102,244

 

414,549

Loans and receivables

23,974

-

-

23,974

Investment in an associate

-

-

69,950

69,950

Other receivables and prepayments

-

-

451

451

Cash held on deposit (maturity date > 3 months)

 

7,968

 

-

 

-

 

7,968

Cash and cash equivalents

-

194,513

-

194,513

Zero Dividend Preference shares

(87,281)

-

-

(87,281)

Other payables

-

-

(8,662)

(8,662)

Total net assets

192,325

259,154

163,983

615,462

 

 

Fixed rate

 

Floating rate

Non interest

bearing

 

Total

28/02/2011

28/02/2011

28/02/2011

28/02/2011

US$ '000

US$ '000

US$ '000

US$ '000

Investments at fair value through profit or loss

 

275,871

 

34,121

 

137,812

 

447,804

Loans and receivables

45,952

-

-

45,952

Other receivables and prepayments

-

-

464

464

Cash and cash equivalents

-

172,267

-

172,267

Zero Dividend Preference shares

(82,341)

-

-

(82,341)

Other payables

-

-

(3,358)

(3,358)

Total net assets

239,482

206,388

134,918

580,788

 

The income receivable by the Company is not subject to significant amounts of risk due to fluctuations in the prevailing levels of market interest rates. However, whilst the income received from fixed rates securities is unaffected by changes in interest rates, the investments are subject to risk in the movement of fair value. The Investment Adviser considers the risk in the movement of fair value as a result of changes in the market interest rate for fixed rate securities to be insignificant, hence no sensitivity analysis is provided.

 

21. Financial risk and management objectives and policies

 

Of the money held on deposit, US$194,513,000 (28 February 2011: US$172,267,000) earns interest at variable rates and the income may rise and fall depending on changes to interest rates.

 

The sensitivity of the bank debt's market value is not influenced by a change in prevailing interest rates, because they are floating rate instruments. The market value of bank debt is influenced by factors such as the performance of the issuer and bank liquidity.

 

Interest rate risk continued

The data below demonstrates the sensitivity of the Company's profit/(loss) for the year to a reasonably possible change in interest rates, with all other variables held constant.

 

The sensitivity of the profit on interest received on cash and cash equivalents is the effect of the assumed changes in the daily interest rates throughout the year to 29 February 2012 and year ended 28 February 2011, on accounts where cash is held:

 

The sensitivity of the profit for the year on investment income received on bank debt is the effect of the assumed changes in the 3 month Libor on which the interest paid was derived.

 

 

Change in basis points increase/(decrease)

Sensitivity of interest income increase/(decrease) receivable on cash and cash equivalents

Sensitivity of interest income increase/(decrease) receivable on bank debt

29/02/2012

28/02/2011

29/02/2012

28/02/2011

US$'000

US$'000

US$'000

US$'000

+25 / -25

383/ (382)

286/ (286)

101 / (101)

150 / (150)

+100 / -100

1,527/ (458)

1,143/ (343)

402 / (402)

599 / (599)

 

The following table analyses the Company's interest rate exposure in terms of the assets and liabilities maturity dates.

 

 

0-3 months

 

4-12 months

 

 

1-2 years

 

 

2-5 years

 

More than 5 years

No maturity date

Non- interest bearing

 

 

Total

29/02/2012

29/02/2012

29/02/2012

29/02/2012

29/02/2012

29/02/2012

29/02/2012

29/02/2012

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

Cash and cash equivalents

 

194,513

 

-

-

-

-

-

-

194,513

Cash held on deposit (maturity date > 3 months)

-

7,968

-

-

-

-

-

7,968

Financial asset at fair value through profit or loss

-

22.043

30,529

138,492

5,110

116,059

102,316

414,549

Loans and receivables

-

16,213

-

7,761

-

-

-

23,974

Investment in associate

-

-

-

-

-

-

69,950

69,950

ZD P shares

-

-

-

(87,281)

-

-

-

(87,281)

Other receivables /payables

-

-

-

-

-

-

(8,211)

(8,211)

194,513

46,224

30,529

58,972

5,110

116,059

164,055

615,462

 

21. Financial risk and management objectives and policies

 

28/02/2011

28/02/2011

28/02/2011

28/02/2011

28/02/2011

28/02/2011

28/02/2011

28/02/2011

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

Cash and cash equivalents

172,267

-

-

-

-

-

-

172,267

Financial asset at fair value through profit or loss

29,995

1,477

20,340

79,069

33,393

145,718

137,812

447,804

Loans and receivables

-

-

9,653

36,299

-

-

-

45,952

ZDP shares

-

-

-

-

(82,341)

-

-

(82,341)

Other receivables

/payables

-

-

-

-

-

-

(2,894)

(2,894)

202,262

1,477

29,993

115,368

(48,948)

145,718

134,918

580,788

 

 

The Investment Adviser monitors the Company's overall interest sensitivity on a regular basis by reference to prevailing interest rates and the level of the Company's cash balances. The Company has not used derivatives to mitigate the impact of changes in interest rates.

 

Credit risk

The Company takes on exposure to credit risk, which is the risk that a counterparty to a financial instrument will cause a financial loss to the Company by failing to discharge an obligation. These credit exposures exist within investment classified as FVTPL, debt investments, loans and receivables and cash [and] cash equivalents.

 

They may arise, for example, from a decline in the financial condition of a counterparty, from entering into derivative contracts under which counterparties have obligations to make payments to the Company. As the Company's credit exposure increases, it could have an adverse effect on the Company's business and profitability if material unexpected credit losses were to occur.

 

In the event of any default on the Company's loan investments by a counterparty, the Company will bear a risk of loss of principal and accrued interest of the investment, which could have a material adverse effect on the Company's income and potential to pay dividends to Shareholders and to redeem the ZDP shares.

 

In accordance with the Company's policy, the Investment Adviser monitors the Company's exposure to credit risk on a regular basis, by reviewing the financial statements, budgets and forecasts of underlying investee companies.

 

The table below analyses the Company's maximum exposure to credit risk. The maximum exposure is shown gross at the reporting date.

 

Total

Total

29/02/2012

28/02/2011

US$ '000

US$ '000

Bank Debt

32,512

34,121

Legacy Portfolio Debt

25,312

42,620

Mezzanine Debt

29,632

48,499

US Micro Cap Debt

181,655

263,500

European Micro Cap debt

85,129

-

Cash held on deposit

7,968

-

Cash and cash equivalents

194,513

172,267

Accrued dividend income

405

405

557,126

561,412

 

A proportion of micro cap and mezzanine debt held does not entitle the Company to interest payment in cash. This interest is capitalised ("PIK") and as a result has substantial credit risk as there is no return to the Company until the loan plus all the interest, is repaid in full.

 

21. Financial risk and management objectives and policies

 

Of the US$5,356,000 (28 February 2011:US$8,807,000) interest that was recognised in the statement of comprehensive income on investments classified as loans and receivables during the year US$360,000 (28 February 2011:US$432,000) was receivable in the form of PIK Investments.

 

There is no collateral held in respect of mezzanine debt forming the loans and receivables.

 

An impairment review is performed by the Investment Adviser on an investment by investment basis every quarter.

 

The movement in the allowance for impairment in respect of loans and receivables during the year was as follows:

 

29/02/2012

28/02/2011

US$ '000

US$ '000

Balance at beginning of year

9,119

20,303

Written off in year

-

(15,341)

Impairment

174

4,157

Balance at year end

9,293

9,119

 

 

The table below analyses the Company's loans and receivables that are either past due or impaired.

 

 

Impairment

Past due

Total

Impairment

Past due

Total

29/02/2012

29/02/2012

29/02/2012

28/02/2011

28/02/2011

28/02/2011

US$ '000

 US$ '000

 US$ '000

US$ '000

US$ '000

US$ '000

Mezzanine portfolio

9,293

-

9,293

9,119

-

9,119

 

Mezzanine investments typically have no or a limited trading market and therefore such investments will be illiquid, and as such the Company's ability to sell them in the short term may be limited.

 

The Investment Adviser closely monitors the creditworthiness of mezzanine debt counterparties and other loans and receivables and upon unfavourable change, may seek to terminate the agreement or to obtain collateral. The credit worthiness is monitored by the reviewing of quarterly covenant agreements and by the Investment Adviser having board representation on a significant number of these investees.

 

The Company has also diversified its portfolio across different industry sectors.

 

Bank debt designated at fair value through profit or loss

 

The Company has also invested in bank debt with investment grade credit ratings as rated by Standard and Poors detailed below.

Credit rating - Bank debt First and Second Lien

Percentage of debt instruments

29/02/2012

28/02/2011

BB

8%

B

13%

3% 

B-

6%

12%

CCC+

41%

-

CCC

-

40%

No rating

40%

37%

100%

100%

 

21. Financial risk and management objectives and policies

 

The following table analyses the concentration of credit risk in the Company's debt portfolio by industrial distribution.

 

29/02/2012

28/02/2011

US$ '000

US$ '000

Healthcare Services and Equipment

26%

25%

Support Services

20%

24%

Financial General

25%

16%

Construction and Materials

1%

14%

Industrial Engineering

11%

12%

Industrial Services

3%

-

House, Leisure and Personal Goods

2%

4%

Electronic and Electrical Equipment

7%

4%

Sensors and Instrumentation

5%

1%

100%

100%

 

 

The table below analyses the Company's deposits and cash and cash equivalents by rating agency category.

 

Credit ratings

Standard& Poor's Outlook

Fitch LT Issuer Default Rating

29/02/2012

28/02/2011

US$ '000

US$ '000

Cash deposits

HSBC Bank USA NA

Stable

AA

8,662

-

Cash and cash equivalents

HSBC Bank USA NA

Stable

AA

142,819

120,330

Deutsche Bank

Negative

A+

51,434

51,240

Jefferies & Company, Inc.

Negative

BBB

-

405

Butterfield Bank (Guernsey) Limited

 

Negative

 

A-

260

292

194,513

172,267

 

Bank debt designated at fair value through profit or loss continued

 

Bankruptcy or insolvency of the Banks may cause the Company's rights with respect to these assets to be delayed or limited. The Investment Adviser monitors risk by reviewing the credit rating of the Bank. If credit quality deteriorates, the Investment Adviser may move the holdings to another bank.

 

Liquidity risk

Liquidity risk is defined as the risk that the Company will encounter difficulty in meeting obligations associated with financial liabilities. Liquidity risk arises because of the possibility that the Company could be required to pay its liabilities earlier than expected.

 

Many of the Company's investments are private equity, mezzanine loans and other unlisted investments. By their nature, these investments will generally be of a long term and illiquid nature and there may be no readily available market for sale of these investments.

 

There are partial restrictions on the saleability of the listed equity of TAL International Group, Inc.

 

The Company has outstanding investment commitments at the year end of US$50,430,000 (2011: US$7,154,000) see note 26. The Company manages liquidity levels to ensure these obligations can be met.

 

21. Financial risk and management objectives and policies

 

The table below analyses the Company's financial liabilities into relevant maturity groups based on the remaining period at the reporting date to the contractual maturity date. The amounts in the table are not discounted to the net present value of the future cash outflows as it is not considered significant.

 

Less than

1 month

 

2-12 months

 

1-5 years

 

>5 years

No stated maturity

US$'000

US$'000

US$'000

US$'000

US$'000

At 29 February 2012

Other payables

8,662

-

-

-

-

Zero Dividend Preference shares

-

-

139,100

-

-

8,662

-

139,100

-

-

 

Less than

1 month

 

2-12 months

 

1-5 years

 

>5 years

No stated maturity

US$'000

US$'000

US$'000

US$'000

US$'000

At 28 February 2011

Other payables

3,358

-

-

-

-

Zero Dividend Preference shares

-

-

-

124,449

-

3,358

-

-

124,449

-

 

 

The Company has a capital requirement to pay ZDP shareholders a pre determined final capital entitlement of 365.28 pence on 22 June 2016. As at 29 February 2012 the liability to the ZDP shareholders amounted to US$87,281,000 (28 February 2011: US$82,341,000).

 

Currency risk

Currency risk is the risk that the value of a financial instrument will fluctuate due to changes in foreign exchange rates.

 

Zero dividend preference shares are denominated in Sterling. The Company has an obligation to redeem the ZDP shareholders on 22 June 2016. The total liability on the redemption date, 22 June 2016, will be GBP76,583,969. The Company currently has no hedge to manage this risk to Sterling.

 

The following table sets out the Company's exposure to foreign currency risk.

 

US dollar

Euro

GB Sterling

Total

29/02/2012

29/02/2012

29/02/2012

29/02/2012

At 29 February 2012

US$'000

US$'000

US$'000

US$'000

Assets

Financial asset at fair value through profit or loss

 

365,905

 

15,179

 

33,465

 

414,549

Loans and receivables

23,974

-

-

23,974

Investment in associate

69,950

-

-

69,950

Other receivables

405

-

46

451

Cash and cash equivalents

194,513

-

7,968

202,481

Total assets

654,747

15,179

41,479

711,405

Liabilities

ZDP shares

-

-

87,281

87,281

Other payables

8,498

-

164

8,662

Total liabilities

8,498

-

87,445

95,943

Net currency exposure

646,249

15,179

(45,966)

615,462

 

21. Financial risk and management objectives and policies

 

US dollar

Euro

GB Sterling

Total

28/02/2011

28/02/2011

28/02/2011

28/02/2011

At 28 February 2011

US$'000

US$'000

US$'000

US$'000

Assets

Financial asset at fair value through profit or loss

 

414,905

 

32,899

 

-

 

447,804

Loans and receivables

45,952

-

-

45,952

Other receivables

434

-

30

464

Cash and cash equivalents

172,164

-

103

172,267

Total assets

633,455

32,899

133

666,487

Liabilities

ZDP shares

-

-

82,341

82,341

Other payables

3,274

-

84

3,358

Total liabilities

3,274

-

82,425

85,699

Net currency exposure

630,181

32,899

(82,292)

580,788

 

22. Fair value of financial instruments

 

The Company classify the measurements of its financial instruments at fair value through profit or loss using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The financial assets valued at fair value through profit or loss are analysed in a fair value hierarchy based on the following levels:

 

·; Quoted prices (unadjusted) in active markets for identical assets or liabilities (level 1).

·; Those involving inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (level 2).

·; Those involving inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (level 3).

 

The level in the fair value hierarchy within which the fair value measurement is categorised in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a level 3 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgement, considering factors specific to the asset or liability.

 

The determination of what constitutes 'observable' requires significant judgement by the Company. The Company considers observable data to be that market data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market.

 

The following table shows financial instruments recognised at fair value, analysed between those whose fair value is based on:

 

Level 1

Level 2

Level 3

Total

Financial assets at 29 February 2012

US$ '000

US$ '000

US$ '000

US$ '000

Financial assets designated at fair value through profit or loss at inception:

Listed securities

154,233

-

-

154,233

Legacy portfolio

-

-

25,312

25,312

Bank debt

-

19,541

12,971

32,512

Mezzanine portfolio

-

-

5,658

5,658

US Micro cap portfolio

-

-

181,655

181,655

European Micro cap portfolio

-

-

15,179

15,179

154,233

19,541

240,775

414,549

 

Level 1

Level 2

Level 3

Total

 

22. Fair value of financial instruments

 

Financial assets at 28 February 2011

US$ '000

US$ '000

US$ '000

US$ '000

Financial assets designated at fair value through profit or loss at inception:

Listed securities

105,016

-

-

105,016

Legacy portfolio

-

-

42,620

42,620

Bank debt

-

25,039

9,082

34,121

Mezzanine portfolio

-

-

2,547

2,547

Micro cap portfolio

-

-

263,500

263,500

105,016

25,039

317,749

447,804

 

When fair values of listed equity and debt securities at the reporting date are based on quoted market prices or binding dealer price quotations (bid prices for long positions), without any deduction for transaction costs, the instruments are included within level 1 of the hierarchy.

 

The fair values of Bank debt which is provided by a broker is classified as level 2. The fair value of bank debt which is derived from unobservable data is classified as level 3.

 

The fair values of investments in the micro cap, legacy and mezzanine portfolios for which there are no active market, are calculated using a valuation model which is accepted in the industry. The model calculates the fair value by applying an appropriate multiple (based on comparable quoted companies, recent acquisition prices and quotes) to the Company's last twelve months EBITDA and deducting a market liquidity discount. The multiples used and marketability discount are classified as unobservable inputs therefore investments are classified as level 3.

 

Transfers between levels

There were no transfers between the levels of hierarchy of financial assets recognised at fair value within the year ended 29 February 2012 and 28 February 2011.

 

The following table shows a reconciliation of all movements in the fair value of financial instruments categorised within level 3 between the beginning and the end of the reporting period.

 

Bank debt

Mezzanine portfolio

Micro cap portfolio

Legacy portfolio

Total

At 29 February 2012

US$ '000

US$ '000

US$ '000

US$ '000

US$ '000

At 1 March 2011

9,082

2,547

263,500

42,620

317,749

Purchases

-

-

67,625

-

67,625

PIK adjusted for fair value

404

30

21,359

2,887

24,680

Cost of investments repaid or sold

-

-

(156,634)

(23,387)

(180,021)

Net gains and losses recognised in statement of comprehensive income

3,474

3,080

1,558

3,098

11,210

Movement in accrued interest recognised in statement of comprehensive income

11

1

(574)

94

(468)

At 29 February 2012

12,971

5,658

196,834

25,312

240,775

 

Bank debt

Mezzanine portfolio

Micro cap portfolio

Legacy portfolio

Total

At 28 February 2011

US$ '000

US$ '000

US$ '000

US$ '000

US$ '000

At 1 March 2011

11,670

2,457

171,903

31,845

217,875

Purchases

-

131

102,349

13,334

115,814

PIK adjusted for fair value

92

20

13,514

2,557

16,183

Cost of investments repaid or sold

(10,000)

-

(70,054)

(26,705)

(106,759)

Net gains and losses recognised in statement of comprehensive income

7,300

(66)

44,213

21,350

72,797

Movement in accrued interest recognised in statement of comprehensive income

20

5

1,575

239

1,839

At 28 February 2011

9,082

2,547

263,500

42,620

317,749

 

 

The following table details the revenues and net gains included within the Statement of Comprehensive Income for investments classified at level 3 which were still held at the year end.

 

 

 

Bank debt

 

Mezzanine portfolio

Micro cap portfolio

 

Legacy portfolio

 

 

Total

At 29 February 2012

US$ '000

US$ '000

US$ '000

US$ '000

US$ '000

Interest and other revenue

1,650

31

26,162

4,301

32,144

Net gain on investments at fair value through profit or loss

3,474

3,080

1,558

3,098

11,210

5,124

3,111

27,720

7,399

43,354

 

Bank debt

Mezzanine portfolio

Micro cap portfolio

Legacy portfolio

Total

At 28 February 2011

US$ '000

US$ '000

US$ '000

US$ '000

US$ '000

Interest and other revenue

1,283

25

20,692

3,143

25,143

Net gain on investments at fair value through profit or loss

7,300

-

44,213

21,350

72,863

8,583

25

64,905

24,493

98,006

 

For the investments measured at level 3 at the reporting date, the Company adjusted the default rate, and discount rate assumptions within a range of reasonably possible alternatives. The extent of the adjustment varied according to the characteristics of each security.

 

The potential effect of using reasonably possible alternative assumptions for valuing financial instruments classified as Level 3 at the reporting date would reduce the fair value by up to US$1,405,000 (28 February 2011: US$6,260,000) or increase the fair value by US$1,625,000 (28 February 2011:US$6,260,000).

 

The fair value of financial assets and financial liabilities measured at amortised cost are determined as follows:

 

The fair value of the Zero Dividend Preference shares is deemed to be their quoted market price. As at 29 February 2012 the ask price was GBP3.09 (28 February 2011: GBP2.725 per share the total fair value of the ZDP shares was US$101,972,999 (28 February 2011: US$91,693,809) which is US$14,476,336 higher (28 February 2011: US$9,087,250 higher) than the liability recorded in the statement of financial position.

 

The carrying amounts of loans and receivables are recorded at amortised cost using the effective interest method in the financial statements. The fair value of loans and receivables at 29 February 2012 was US$23,974,000 (28 February 2011: US$45,952,000).

 

The carrying amounts of trade receivables and trade payables are deemed to be their fair value due to their short term nature.

 

23. Basic and Diluted Earnings per share

Basic and diluted earnings per share are calculated by dividing the earnings for the period by the weighted average number of Ordinary shares outstanding during the period.

 

For the years ended 29 February 2012 and 28 February 2011 the weighted average number of Ordinary shares (including Limited voting ordinary shares) outstanding during the period was 65,018,610.

 

24. Net Asset Value Per Share

The net asset value per Ordinary share of US$9.47 (28 February 2011: US$8.93) is based on the net assets at the year end of US$615,462,000 (28 February 2011: US$580,788,000) and on 65,018,610 (28 February 2011: 65,018,610) Ordinary shares, being the number of Ordinary shares in issue at the year end.

 

25. Notes to the cash flow statement

 

Reconciliation of the profit for the year to net cash from operating activities.

 

Year ended

Year ended

29/02/2012

28/02/2011

US$ '000

US$ '000

Profit for the year

45,044

137,243

Increase in other payables

4,514

2,286

Decrease in receivables relating to operating activities

13

189

Net movement in unrealised gains on investments

11,284

(90,189)

Net impairments on loans and receivables

174

3,369

Share of associates income

(20,797)

-

Net unrealised foreign currency exchange losses/(gains)

(1,706)

5,002

Realised gain on investments - financing activity

(18,654)

(30,789)

Interest on investments received as PIK adjusted for increase in accrued interest

 

(24,124)

 

(17,993)

Interest receivable from treasury gilts reinvested

(696)

-

Finance costs in respect of ZDP shares

6,581

 

5,938

 

Net cash from operating activities

1,633

15,056

 

 

Investment income received during the year

Year ended

Year ended

29/02/2012

28/02/2011

US$ '000

US$ '000

Interest on investments

14,459

17,648

Dividends from listed investments

3,882

3,322

Interest on short term fixed deposits

-

1,413

Bank interest

486

352

Interest on treasury notes

-

286

Other income

124

3

18,951

23,024

 

Purchases and sales of investments are considered to be operating activities of the Company, given its purpose, rather than investing activities. The cash flows arising from these activities are shown in the Cash Flow Statement.

 

26. Commitments

 

At 29 February 2012 JZCP had the following financial commitments outstanding in relation to fund investments:

 

Year ended

Year ended

29/02/2012

28/02/2011

US$ '000

US$ '000

EuroMicrocap Fund 2010, LP

33,347

-

Asset management company*

15,000

-

Milestone Aviation Group, Inc.

2,083

7,154

50,430

7,154

 

*JZCP has made a commitment to invest up to US$15 million into an entity to be formed that will provide asset management services to third party clients.

 

 

27. Related Party Transactions

In 2007, JZEP invested US$250,000 in ETX Holdings, Inc. which was a spin off of Jordan Auto Aftermarket Holdings, Inc., a former co-investment with The Jordan Company. The investment was subsequently transferred to JZCP as part of the in specie transfer dated 1 July 2008. A further US$142,000 has subsequently been invested in ETX Holdings, Inc. During the years ended 29 February 2012 and 28 February 2011 the Company did not receive any income from this investment. At 29 February 2012 the investment was valued at US$602,000 (28 February 2011: US$534,000).

 

At 29 February 2012, JZCP has invested US$49,153,000 (28 February 2011: US$30,488,000 in the EuroMicrocap Fund 2010 LP ("The Europe Fund"). At 29 February 2012 the investment was valued at US$69,950,000 (28 February 2011: US$32,899,000). The Europe Fund is managed by JZ International LLC ("JZI"), an affiliate of JZAI, JZCP's investment manager. JZAI and JZI were each founded by David Zalaznick and Jay Jordan.

 

The Company has invested with The Resolute Fund, which is managed by the Jordan Company, a company in which David Zalaznick and Jay Jordan are Managing Principals. These investments include: Kinetek, Inc.; TAL International Group, Inc.; TTS, Llc and represent an aggregate value of US$71,154,000 at 29 February 2012 (28 February 2011: US$70,102,000). Woundcare Services, Inc., another co-investment with the Resolute Fund was sold during the year for US$63,918,000 (28 February 2011 value: US$41,114,000).

 

The Company has invested with Fund A, a Limited Partnership in a number of US micro cap buyouts. Fund A is managed by JZAI. At 29 February 2012 the total amount of these co-investments was US$53,905,000 (US$44,203,000 invested by the Company and US$9,702,000 invested by Fund A).

 

Jordan/Zalaznick Advisers, Inc. (JZAI), a US based company, provides advisory services to the board of Directors of the Company in exchange for management fees, paid quarterly. Fees paid by the Company to the Investment Adviser are detailed in Note 9. In addition, the Investment Adviser and its associates are entitled to a variety of fees from investee companies and transactions therein.

 

During the year ended 29 February 2012, the Company retained Ashurst LLP, a UK based law firm. David Macfarlane was a former Senior Corporate Partner at Ashurst until 2002.

 

The Directors remunerations are disclosed in Note 9.

 

28. Controlling Party

The issued shares of the Company are owned by a number of parties, and therefore, in the opinion of the Directors, there is no ultimate controlling party of the Company, as defined by IAS 24 - Related Party Disclosures.

 

29. Contingent Assets

Amounts held in escrow accounts

Investments have been disposed by the Company, of which the consideration given included contractual terms requiring that a percentage was held in an escrow account pending resolution of any indemnifiable claims that may arise. At 29 February 2012 the Company has assessed that the fair value of these escrow accounts are nil as it is not reasonably probable that they will be realised by the Company.

 

As at 29 February 2012, the Company had the following contingent assets held in escrow accounts which had not been recognised as assets of the Company:

29/02/2012

28/02/2011

Company

US$ '000

US$ '000

GHW (G&H Wire)

3,031

3,031

Dantom Systems, Inc.

2,415

-

Wound Care Solutions, Llc

5,398

-

Advanced Chemistry & Technology, Inc.

1,772

-

Recycled Holdings Corporation

1,300

1,300

Apparel Ventures, Inc.

428

1,039

N&B Industries, Inc.

776

776

Gear for Sports

186

248

15,306

6,394

29. Contingent Assets

 

During the year US$2,093,000 (28 February 2011: 2,553,000) was realised relating to the escrow accounts of the Company.

 

Income incentive fee

During the year ended 29 February 2012 an income incentive fee of $4,409,700 was paid to the Investment Adviser relating to income earned and an increase in the valuation of PIK investments during the quarter ended 30 November 2011. Under the terms of the Advisory Agreement the income earned for the year ending 29 February 2012 did not exceed the required annual hurdle for a fee to be payable to the Investment Adviser therefore the amount paid in the year is repayable to the Company on termination of the Advisory Agreement or offset against any future income incentive fees payable. As neither a date for the termination of the Advisory Agreement or the event of any future income incentive fees becoming payable can be predicted the amount of US$4,409,700 is treated as a contingent asset.

 

30. Dividends paid and proposed

A final dividend for the year ended 28 February 2011 of 7.5 cents per Ordinary share (total US$4,876,396) and a special dividend of 2.0 cents (total US$1,300,372) was paid 1 July 2011.

 

An interim dividend of 3.5 cents per Ordinary share (total US$2,275,651) and a special dividend of 3.0 cents per share (total US$1,950,558) was paid on 25 November 2011.

 

A final dividend of 18.5 cents per Ordinary share (total US$12,028,443) was proposed by the Board on 17 May 2012.

 

In accordance with the new dividend policy, it will be the Directors' intention for the year ending 28 February 2013 and thereafter to distribute substantially 3% of the Company's net assets in the form of dividends paid in US dollars (shareholders can elect to receive dividends in Sterling). Prior to the new policy, the Directors have distributed substantially all of the Company's net cash income (after expenses) in the form of dividends.

 

31. Subsequent events

The Company invested in Bay Valve Service and Engineering, a Seattle Washington based refurbisher of larger valves for a variety of end users, from oil refineries to power generation plants. JZCP invested US$18.7 million in debt and equity securities, including 31% of the business's equity.

 

An investment was made in Medplast/UPG, a plastic molding company specialising in high margin healthcare molded products. JZCP purchased US$17.5 million of securities, including US$10.0 million of 14.5% subordinated notes and US$7.5 million of preferred and common equity. The equity represents a fully diluted 11% of the business.

 

The Company invested US$6.2 million in BSM Engenharia, a Brazil based infrastructure service business.

 

Via a partnership with an experienced real estate developer, the Company completed the purchase of almost an entire square block in Williamsburg, Brooklyn one of the fastest growing neighborhoods in New York City. JZCP purchased over 100,000 square feet of retail units and forty apartments for approximately US$64 million. JZCP invested US$14.25 million in equity in this partnership.

 

The EuroMicrocap Fund 2010, LP ("EMF") acquired 29.7% of Oro Direct, a precious metals trading business in Spain. EMF paid €13.5 million for its share of this growing and scaleable business. JZCP has 75% ownership of EMF.

 

In March and May 2012, JZCP sold 708,320 shares of TAL International Group, Inc ("TAL") in two secondary offerings realising proceeds of US$26.7 million.

 

One of the Company's micro cap investments repaid their subordinated debt obligations, resulting in a total repayment of US$9.0 million which represented the fair value of the investment at 29 February 2012.

 

31. Subsequent events

 

The Company has made a series of proposals to Ordinary and LVO shareholders. These proposals are described in the Chairman's statement and are subject to shareholders approval.

 

A final dividend of 18.5 cents per Ordinary share (total US$12.0 million) was proposed by the Board.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR BKODNOBKDNPD
Date   Source Headline
8th May 202412:45 pmPRNExtraordinary General Meeting
22nd Apr 20243:03 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNProposed Investment in the Secondary Fund for the Purpose of Investing in Follow-on Flex Pack and Proposed Return of Capital and Notice of Extraordinary General Meeting
22nd Mar 20243:00 pmPRNNet Asset Value(s)
21st Feb 202411:55 amPRNNet Asset Value(s)
13th Feb 20249:43 amPRNHolding(s) in Company
22nd Jan 20244:44 pmPRNNet Asset Value(s)
21st Dec 20235:01 pmPRNNet Asset Value(s)
20th Dec 202311:20 amPRNDirector/PDMR Shareholding
18th Dec 20237:00 amPRNRepayment of Senior Facility
14th Dec 20237:00 amPRNUpdate in relation to Secondary Sale
22nd Nov 20235:20 pmPRNNet Asset Value(s)
9th Nov 20237:00 amPRNHalf-year Report
23rd Oct 20232:36 pmPRNNet Asset Value(s)
22nd Sep 20233:09 pmPRNNet Asset Value(s)
21st Aug 20233:00 pmPRNNet Asset Value(s)
25th Jul 20233:59 pmPRNResult of AGM
21st Jul 20233:00 pmPRNNet Asset Value(s)
27th Jun 202310:29 amPRNNotice of AGM
21st Jun 20234:30 pmPRNNet Asset Value(s)
23rd Jun 20224:40 pmRNSSecond Price Monitoring Extn
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
1st Jun 20226:26 pmPRNNet Asset Value(s)
23rd May 20227:00 amPRNFurther Update in relation to Secondary Sale
7th Apr 20227:00 amPRNUpdate: Secondary Sale and
1st Apr 20224:40 pmRNSSecond Price Monitoring Extn
1st Apr 20224:36 pmRNSPrice Monitoring Extension
23rd Mar 202210:35 amPRNNet Asset Value(s)
21st Mar 20227:00 amPRNJZCP European Micro Cap Investments
21st Feb 202210:28 amPRNNet Asset Value(s)
31st Jan 202211:06 amRNSSecond Price Monitoring Extn
31st Jan 202211:01 amRNSPrice Monitoring Extension
26th Jan 20226:07 pmPRNJZCP Agrees New Senior Facility
21st Jan 20229:34 amPRNNet Asset Value(s)
21st Dec 20219:25 amPRNNet Asset Value(s)
22nd Nov 20219:39 amPRNNet Asset Value(s)
11th Nov 20217:00 amPRNHalf-year Report
9th Nov 202110:00 amPRNNotice of Interim Results
1st Nov 20212:41 pmPRNDirector Declaration
21st Oct 20219:43 amPRNNet Asset Value(s)
7th Oct 20217:00 amPRNSenior Facility Amendments
6th Oct 20212:53 pmPRNDirector Declaration
24th Sep 20219:39 amPRNNet Asset Value(s)
23rd Aug 20219:01 amPRNNet Asset Value(s)
12th Aug 20214:41 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
12th Aug 20212:06 pmRNSSecond Price Monitoring Extn
12th Aug 20212:00 pmRNSPrice Monitoring Extension
30th Jul 202111:23 amPRNIssue of Loan Notes & Shares, Redemption of Loan Stock
21st Jul 20219:51 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.